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EXPLANATION OF DISSERTATION FORMAT 
This dissertation has been prepared in the alternate 
format as suggested in the Iowa State Graduate College Thesis 
Manual. Use of the alternate format allows preparation of 
articles that will be in a form suitable for submission to a 
scientific journal for publication. 
This dissertation contains a review of literature of 
current topics pertinent to the research presented. Four 
separate papers follow the Literature Review. These papers 
have been prepared from research performed partially to 
fulfill requirements for the Ph.D. degree. Each paper is 
complete and contains an abstract, an introduction to the 
problem, materials and methods, results and discussion, and 
the cited references. Following the last paper, there is a 
general summary that is intended briefly to present the major 
conclusions drawn from the research and to offer suggestions 
for future research. 
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INTRODUCTION 
According to Borland's Illustrated Medical Dictionary 
(1981), atherosclerosis is an extremely common form of 
hardening and thickening of the intima and media of large-
and medium-sized arteries in which plaques (atheromas) 
develop and accumulate cholesterol, lipids, and lipophages 
(e.g., foam cells). Atherosclerosis generally precedes 
coronary heart disease (CHD), a term used to describe anoxia 
of heart muscle because of inadequate circulation. 
As a result of atherosclerosis and other factors, more 
than 1.25 million heart attacks and more than a half-million 
heart attack deaths occur each year in the United States. 
The monetary loss because of morbidity and mortality from CHD 
in 1985 was estimated by the National Heart, Lung, and Blood 
Institute at $49 billion. Because of its costs both in 
monetary terms and in terms of human life and well being, 
much research has been done and will continue to be done on 
the etiology, progression, and prevention of atherosclerosis. 
Several risk factors thus far have been implicated in the 
etiology of atherosclerosis; these include elevated blood 
cholesterol, hypertension, and cigarette smoking (Surgeon 
General's Report, 1988), with hypercholesterolemia probably 
being the primary risk factor. 
Diet plays a pivotal role in the control of 
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hypercholesterolemia. Type and amount of dietary fat 
contribute significantly to control of blood cholesterol 
concentration. It generally is believed that saturated fatty 
acids, especially those with chain lengths of 12 to 16 
carbons, are most hypercholesterolemic. Another saturated 
fatty acid, stearic acid (C18;0), probably plays a neutral 
role in control of concentration of blood cholesterol and may 
even decrease it, whereas palmitic acid (C16:0) is 
hypercholesterolemic (Bonanome and Grundy, 1988). 
Monounsaturated fatty acids, such as oleic acid (C18:l), are 
hypocholesterolemic or, at worst, neutral in their effects on 
blood cholesterol concentration (Mattson and Grundy, 1985). 
Polyunsaturated fatty acids, such as linoleic acid (C18:2), 
are hypocholesterolemic. This action may be because 
polyunsaturated fatty acids can decrease concentrations of 
some of the types of lipoproteins (Vega et al., 1982). 
Amount of fat ingested also can affect concentration of 
plasma cholesterol; high fat diets increase risk of 
hypercholesterolemia, whereas low fat diets decrease the risk 
(Groot and Scheek, 1984). Findings such as these are the 
basis for the recommendations put forth in the Surgeon 
General's Report (1988). Recommendations are to consume no 
more than 30% of total calories as fat, with saturated fatty 
acids less than 10% of calories, monounsaturated fatty acids 
at 10% of calories, and polyunsaturated fatty acids at 10% of 
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calories and to limit cholesterol intake to 300 mg/day. 
Many other dietary factors besides type and amount of 
fat are thought to influence concentration of plasma 
cholesterol as well, including amount of dietary cholesterol 
(Mattson, 1972), source of dietary protein (Sirtori et al., 
1979), type and amount of carbohydrate (including fiber) 
intake (Keys, 1970), and various vitamins and minerals (Hines 
et al., 1985; Blankenhorn et al., 1987; Foley et al., 1990), 
as well as other dietary components. Several reviews of the 
effects of diet on cholesterol metabolism and balance have 
been published (Jacobson, 1974; Grundy, 1983; Goldberg and 
Schonfeld, 1985; McNamara, 1987). 
Recently, researchers have considered the effects of 
postprandial lipoproteins on risk of CHD because humans spend 
a large proportion of the day in the postprandial state. 
Most research, however, has been conducted on fasted subjects 
in an effort to improve reproducibility of experimental 
studies and to establish metabolic baselines. Lipoprotein 
composition and concentration undergo major changes after 
ingestion of a meal, especially one containing a significant 
proportion as dietary fat. Postprandial lipoproteins must be 
considered in the quest to control CHD because changes in 
composition and concentration of lipoproteins induced by 
feeding have been implicated in increased lipoprotein 
atherogenicity (Zilversmit, 1979). With this question in 
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mind, we performed a preliminary study on the effect of type 
and amount of dietary fat on composition of postprandial 
lipoproteins to help assess the relative atherogenicity of 
postprandial lipoproteins. 
The major excretory route of cholesterol from the body 
is through the bile in the form of bile acids and biliary 
cholesterol and the subsequent loss of some fraction of these 
into the feces. The type of fat ingested has been shown to 
affect biliary excretion of neutral and/or acid sterols. 
Some researchers suggest that polyunsaturated fatty acids in 
the diet increase excretion of these biliary constituents 
(Balasubramaniam et al., 1985), whereas other researchers 
find no differences in the effect of type of fat fed on 
biliary excretion (Grundy and Ahrens, 1970). Because bile 
acid metabolism is related so closely to cholesterol 
metabolism and therefore CHD, a study presented herein was 
done to determine the effects of type and amount of dietary 
fat not only on cholesterol homeostasis but on biliary 
composition as well. 
Studies using humans as experimental subjects are 
difficult to control carefully because of frequent lack of 
compliance with experimental diets and protocols. In 
addition, one must be concerned with ethical considerations. 
Pigs are an excellent model for humans when studying CHD 
because pigs can consume diets similar to a human diet, are 
6 
anatomically and physiologically similar to humans, and 
develop spontaneous hypercholesterolemia and atherosclerosis 
(Phillips and Tumbleson, 1986). In addition, because of 
their size, swine can be used conveniently for procedures 
requiring multiple sampling and surgical modifications 
(Dodds, 1982). Because they are excellent models for humans, 
pigs were used to test the hypothesis that the fatty acid 
composition of dietary fats affect secretion of cholesterol 
from plasma into bile as bile acids or biliary cholesterol by 
altering the fluidity (or rigidity) of liver cell membranes 
caused by changes in membrane fatty acid and cholesterol 
composition. The specific objectives of this study were to 
determine the effect of type and amount of dietary fat on 1) 
the amount of plasma cholesterol that is transferred to bile 
as cholesterol or as bile acids, 2) cholesterol content and 
fatty acid composition of liver membranes and biliary 
phospholipids of pigs fed different types of fat, and 3) 
cholesterol concentration of liver, skeletal muscle, aorta, 
heart, and gastrointestinal tract, excluding esophagus, 
rectum, and accessory organs. 
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REVIEW OF LITERATURE 
Cholesterol Metabolism 
Synthesis 
Cholesterol can enter the body by one of two ways, 
either by dietary intake and subsequent absorption (300-500 
mg/day) or by in vivo synthesis in almost all body tissues 
(700-800 mg/day) (Turley and Dietschy, 1982). There is 
essentially only one major pathway for cholesterol synthesis 
in the body and it can be considered to begin with acetyl 
coenzyme A (acetyl-coA) which is ubiquitous in the mammalian 
body. The overall, simplified equation of cholesterol 
synthesis is: 
18 CH3CO-S-C0A + 10 H*+ 1/2 Og -» 
^27^46° (cholesterol) + 9 CO^ + 18 CoA-SH 
(Sabine, 1977). 
The first steps of cholesterol synthesis are utilization 
of three acetyl-CoA units to form /3-hydroxy-/9-methylglutaryl 
coenzyme A (HMG-CoA). There is debate as to whether these 
steps are cytosolic or microsomal (Ott and Lachance, 1981). 
/3-Hydroxy-/3-methylglutaryl coenzyme A then is reduced with 
two molecules of nicotinamide adenine dinucleotide phosphate 
(NADPH) through the activity of the enzyme /3-hydroxy-/3-
methylglutaryl-coenzyme A reductase (HMG-CoA reductase) to 
form mevalonic acid. This step is essentially irreversible. 
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and HMG-CoA reductase is the key enzyme in the physiological 
control of mammalian cholesterol biosynthesis (Brown and 
Goldstein, 1986). These steps occur primarily in the 
microsomal fraction of the cell. Six mevalonic acid 
molecules then form a sgualene molecule through a series of 
phosphorylations, decarboxylations to form isoprene units, 
and subsequent condensations of the isoprene units to form 
the end product, sgualene (C^QH^Q) (Rudney and Sexton, 1986). 
After sgualene synthesis, a microsomal enzyme, sgualene 
epoxidase, is responsible for incorporation of molecular 
oxygen into sgualene. At this point, cyclization occurs 
through the activity of 2,3-oxidosgualene sterol cyclase 
(found in the microsome) to eventually form lanosterol. The 
conversion of lanosterol (C^q) to cholesterol (C^^) involves 
demethylation and reduction and transfer of double bonds 
(Sabine, 1977). 
The whole multienzymic process of cholesterol synthesis 
from lanosterol is essentially membrane-bound. Not only are 
the enzymes bound to the endoplasmic reticulum, but the 
initial, intermediate, and final products are as well, 
probably through a sterol carrier protein. 
As stated, cholesterol synthesis occurs in almost all 
mammalian organs. The organs of highest activity on a weight 
basis in most species are the liver and small intestine, 
especially the ileum (Dietschy and Wilson, 1970). It must be 
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considered, however, that other tissues, although their 
synthetic rate is slow on a weight basis, will contribute 
significant amounts of cholesterol to body pools because of 
their large mass; examples would include skin (Spady and 
Dietschy, 1983) and adipose tissue (Angel and Bray, 1979). 
Cholesterol synthesis is a highly regulated process, 
primarily occurring through regulation of HMG-CoA reductase. 
It generally is agreed that many factors can modulate the 
activity of HMG-CoA reductase. One of the primary controls 
is through negative feedback of cholesterol, especially 
cholesterol contained in low-density lipoprotein (LDL), to 
decrease the concentration of the major regulatory enzyme 
(Brown and Goldstein, 1980; Goldstein and Brown, 1984). 
Intracellular cholesterol derived from LDL causes a decrease 
in the amount of HMG-CoA reductase enzyme by accelerating its 
degradation and decreasing its synthesis rate as seen in 
studies done with rat hepatocytes (Edwards et al., 1983) and 
with Chinese hamster ovary cells (Chang et al., 1981). The 
mechanism of degradation of the enzyme is controversial but 
may involve phosphorylation of the enzyme (Kennelly and 
Rodwell, 1985) or an indirect effect of cholesterol on the 
physical properties of the microsomal membrane where HMG-CoA 
reductase resides (Ide et al., 1980). The latter mechanism 
may be induced by changes in the membrane fluidity, thus 
making the enzyme more susceptible to degradation by 
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proteases in the cytosol. 
Several dietary factors, as well, can control hepatic 
cholesterogenesis. These may include dietary fat, vitamins A 
and D, and proteins. These dietary factors will be discussed 
at length in other sections. In addition, several extensive 
reviews on regulation of cholesterol biosynthesis have been 
published (Ott and Lachance, 1981; Chang, 1983; Rudney and 
Sexton, 1986). 
lipoprotein metabolism 
Cholesterol in the body is transported by particles 
called lipoproteins. There are four primary classes of 
lipoproteins: chylomicrons, very low-density lipoproteins 
(VLDL), LDL, and high-density lipoproteins (HDL). As the 
names imply, the particles differ in density caused by 
varying concentrations of lipid and protein in the particle. 
Chylomicrons have a density of less than 0.94 g/mL, are rich 
in triacylglycerol, and have less than 4% protein. Very low-
density lipoproteins have a density of 0.94-1.006 g/mL and 
contain slightly more protein than do chylomicrons. Low-
density lipoproteins have a density of 1.006-1.063 g/mL and 
have significantly more protein, phospholipid, and 
cholesterol and significantly less triacylglycerol than do 
VLDL. High-density lipoproteins have a density range of 
1.063-1.21 g/mL; they contain less cholesterol than do LDL 
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but significantly more protein and phospholipid, thus 
accounting for their increased density (Sabine, 1977). 
Besides de novo synthesis, a second major source of 
cholesterol input into the body is by the diet. Dietary as 
well as endogenous cholesterol in the intestinal lumen is 
incorporated into micelles with triacylglycerol, 
phospholipids, and bile acids. Cholesterol is absorbed by 
passive diffusion from the intestinal lumen as free 
cholesterol and moved into the enterocyte (Westergaard and 
Dietschy, 1976). In the enterocyte, the cholesterol is 
reesterified and packaged into chylomicrons. 
The chylomicron, the major transport vehicle of newly 
absorbed dietary cholesterol, consists primarily of 
triacylglycerols containing long-chain dietary fatty acids 
and cholesterol esters formed from the dietary cholesterol. 
Small amounts of phospholipid and protein are also present. 
The primary protein associated with chylomicrons is 
apolipoprotein B^g (apoB^g), which is synthesized only in the 
small intestine (Kane et al., 1980). The chylomicron then is 
released from the base of the intestinal epithelial cell and 
enters the intestinal lymphatic vessels where the particles 
obtain apolipoproteins A-I (apoAI) and A-IV (apoAIV). 
Chylomicrons then enter the bloodstream where they interact 
with HDL to acquire apolipoproteins CII, CIII, and E (apoCII, 
apoCIII, and apoE) (Havel, 1987). 
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Chylomicrons are catabolized partly by lipoprotein 
lipase, an enzyme that is situated on the capillary 
endothelial cells of most tissues. Lipoprotein lipase is 
activated by apoCII, which is located on the surface of the 
chylomicron (Bengtsson and Olivecrona, 1980). This enzyme 
catalyzes the hydrolysis of triacylglycerols and 
phospholipids to free fatty acids, glycerol, and 
lysophospholipids that then can be taken up by tissues. 
It is recognized now that triacylglycerol hydrolysis and 
removal from chylomicrons is only the first step in 
chylomicron particle catabolism. The residual chylomicron 
particle is called the chylomicron remnant and consists 
primarily of cholesteryl esters, phospholipid, and apoB and 
apoE. With loss of triacylglycerol and apoCII, the 
chylomicron remnant has little affinity for lipoprotein 
lipase (Havel et al., 1980), is taken up primarily by the 
liver by endocytosis, and delivers its load of absorbed 
cholesterol to the liver lysosomes (Jones et al., 1984). The 
mechanism of remnant uptake is receptor-mediated, and the 
receptor recognizes apoE as the binding ligand. The rate of 
acetyl-CoA conversion to cholesterol in the liver generally 
varies inversely with the rate of cholesterol delivery to the 
liver by chylomicron remnants (Nervi and Dietschy, 1975; 
Nervi et al., 1975). The cholesterol received into the liver 
from the chylomicron remnants can be used for membrane 
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synthesis, biliary secretion, or resecretion from the liver 
after incorporation into other lipoproteins. In addition, 
chylomicron remnants have been shown to undergo endocytosis 
into macrophages to form potentially atherogenic foam cells 
(Goldstein et al., 1980). 
Very low-density lipoproteins are produced by the liver 
and contain primarily triacylglycerol and apolipoprotein 
(apoB^og), apoC, and apoA. Apolipoprotein is the form 
of apoB required for secretion of VLDL by the liver (Kane et 
al., 1980). The triacylglycerols contained in VLDL are 
synthesized from nonesterified fatty acids in circulation or 
from other plasma lipoproteins (Schonfeld and Pfleger, 1971). 
The VLDL resemble chylomicrons in structure and catabolism of 
the triacylglycerol component by lipoprotein lipase (Cryer, 
1981) but contain slightly less triacylglycerol and more 
cholesterol and are slightly smaller in diameter (Linscheer 
and Vergoesen, 1988). The VLDL also acquire apoCII and apoE 
from HDL immediately after secretion. Very low-density 
lipoprotein remnants are formed after triacylglycerol 
removal, and, in normal individuals, the remnants are 
modified quickly to form intermediate-density lipoproteins 
(IDL) (Brown et al., 1981). 
Cholesteryl esters are transferred back to IDL particles 
from HDL particles by a plasma cholesteryl ester exchange 
protein (Fielding and Fielding, 1980). These cholesteryl 
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esters are formed in HDL by the enzyme lecithin-cholesterol 
acyltransferase (LCAT) from free cholesterol removed from 
VLDL. The cholesteryl ester transfer occurs partly, but not 
entirely, through the action of lipid transfer proteins, a 
transfer factor that is absent in rats and swine but present 
in humans and rabbits (Barter et al., 1987). As a result of 
the transfer of cholesteryl ester to IDL, the core 
composition of IDL is changed, the IDL is released from the 
capillary wall, all apolipoproteins except apoB^gg are 
removed, and the particle becomes LDL (Brown et al., 1981). 
As a result of these changes in the lipoproteins, LDL 
contain mostly cholesteryl esters and a trace amount of 
triacylglycerol in the lipid core. The apolipoprotein 
component is almost exclusively apoB^gg (Mahley et al., 
1984). As stated, LDL is formed by VLDL remnants, but 
evidence also exists suggesting that LDL is secreted directly 
from the liver (Thompson et al., 1976; Soutar et al., 1979; 
Janus et al., 1980). Babiak and Rudel (1987) found that 25 
to 75% of LDL in plasma are derived by direct secretion from 
the liver, depending on the species. Marzetta and others 
(1989) indicated that 4-66% of a dose of hepatic VLDL 
containing apoB^g^ injected into African green monkeys was 
metabolized extremely rapidly into particles that resembled 
the recipient's plasma LDL according to size and density. In 
addition, a variable fraction of VLDL is not converted to LDL 
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but is endocytized into hepatocytes by the LDL receptor 
(Havel, 1984). 
Low-density lipoproteins are removed from plasma by 
binding to high affinity receptors in plasma membranes of 
extrahepatic cells and liver. Once there, LDL then is 
internalized by endocytosis (Rafai, 1986). Most cells, 
however, satisfy their need for cholesterol by synthesizing 
the small amount required without expressing the LDL receptor 
(Rudel et al., 1986). Liver has the highest amount of LDL 
receptor activity. Brown and Goldstein (1984) showed that 
liver clears at least two-thirds of the LDL taken from plasma 
each day, and 80-90% of this clearance is by the LDL receptor 
mechanism in rat and rabbit. Shepherd and others (1979) 
reported 78% of the LDL taken from plasma by liver was via 
the LDL receptor mechanism in humans. 
Low-density lipoproteins that are taken into hepatocytes 
by the LDL receptor seem to be processed by the pathway of 
receptor-mediated endocytosis. Once lipoproteins are bound 
to the receptor by the ligand apoB^gg, the LDL-receptor 
complex migrates to the coated pits on the hepatocyte 
membrane (Brown and Goldstein, 1976). The material coating 
the pits is clathrin (Havel, 1986). The LDL-receptor complex 
then is internalized and forms endosomes. The endosomes fuse 
with one another or with pre-existing intracellular 
compartments soon after endocytosis. • The endosomes then bind 
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with lysosomes (Brown and Goldstein, 1976). The protein 
component of LDL is degraded rapidly in the lysosome to free 
amino acids that are released from the cell (Goldstein et 
al., 1975). The cholesteryl ester core of LDL is hydrolyzed 
by a lysosomal acid lipase (Brown et al., 1975). The fate of 
the free cholesterol produced by this action will be 
discussed later. The receptors are recycled to the cell 
surface within minutes after endocytosis. Low-density 
lipoprotein release from the receptor is thought to occur 
because of acidic pH in the endocytic vesicles before 
receptors return to the cell surface (Havel, 1986). 
Hepatic LDL receptors are regulated by hepatic 
cholesterol in rabbits and dogs in such a way that as hepatic 
cholesterol concentration increases the number of receptors 
decreases (Kovanen et al., 1981a), and when animals are bile 
acid depleted, as with feeding of bile acid sequestrants, the 
number of hepatic LDL receptors increases (Kovanen et al., 
1981b). In contrast, however, Spady and Dietschy (1985) 
demonstrated that the number of hepatic LDL receptors in 
hamsters was expressed independently of hepatic cholesterol 
concentration but was somewhat dependent on the type of 
dietary fat. 
The importance of the LDL receptor in controlling blood 
cholesterol concentration is evident after consideration of 
patients with familial hypercholesterolemia. This genetic 
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disorder is a mutation in the LDL receptor of humans such 
that the LDL receptor is decreased greatly in number or is 
absent (Havel, 1986). These patients have very high 
concentrations of blood cholesterol and die in young 
adulthood of coronary heart disease. 
Macrophages can ingest LDL through several pathways. 
Human macrophages possess a high-affinity receptor for native 
LDL, and is down regulated by high cholesterol concentration. 
Macrophages also contain a receptor system that is not 
regulated termed the "scavenger receptor" system. This 
recepotr system binds to modified LDL very readily (Clarke et 
al., 1987). Low-density lipoproteins also can be degraded by 
non-receptor mechanisms in macrophages or scavenger cells. 
This pathway occurs primarily when there are high 
concentrations of plasma LDL. Often in these conditions, the 
scavenger cells are overloaded with cholesteryl ester from 
LDL and are converted into foam cells, which are components 
of atherosclerotic plagues (Brown et al., 1981). Hoffman and 
coworkers (1988) used DNA encoding the human LDL receptor 
that was under control of mouse metallothionein-I promoter in 
transgenic mice to determine if increasing the relative 
number of LDL receptors would result in a clearing of I-
labeled LDL from blood more rapidly than in normal mice. 
They found an 8-10 times more rapid clearance and concluded 
that overexpression of the receptor could lower dramatically 
18 
the concentration of LDL in these transgenic mice. 
There are many fates and functions of free cholesterol 
obtained via LDL endocytosis. This cholesterol is used for 
membrane synthesis (Brown et al., 1981) and also has 
regulatory roles in maintaining cholesterol homeostasis. 
These regulatory roles are three-fold; free cholesterol in 
the liver cell 1) suppresses HMG-CoA reductase, which turns 
off cholesterol synthesis in the cell, 2) activates acyl-
CoA:cholesterol acyltransferase, which reesterifies excess 
cholesterol for storage as cholesteryl esters, and 3) 
suppresses the synthesis of the LDL receptor protein, which 
prevents accumulation of cholesterol in the cell from 
receptor-mediated endocytosis (Brown and Goldstein, 1976; 
Brown et al., 1981). Researchers have investigated LDL-
cholesterol conversion to biliary components as well. 
Kuipers and coworkers (1989) concluded that the uptake of 
human LDL by the liver of rats is not efficiently coupled to 
biliary secretion of cholesterol as biliary cholesterol or 
bile acids, yet there is some conversion of LDL-cholesterol 
in liver to biliary constituents. 
Some researchers have separated LDL into two subclasses. 
Swinkels and others (1988) suggest two subfractions of LDL, 
LDL-1 and LDL-2, with density ranges of 1.023-1.034 and 
1.036-1.041 g/mL, respectively. In this study, no 
differences between the two subclasses were found for binding 
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and internalization or degradation. However, kinetic studies 
in guinea pigs showed that LDL-2 disappeared faster from 
circulation and therefore tended to accumulate in the liver 
more quickly than did LDL-1. This observation suggests that 
LDL-1 is more atherogenic than is LDL-2 because its longer 
half-life in plasma increases its probability for uptake by 
the scavenger LDL receptor on macrophages. Austin and Krauss 
(1986) also found evidence of two LDL subclasses by gradient-
gel electrophoresis. The first class, LDL-A, was a smaller, 
denser particle found in 15% of the subjects studied. 
Persons with LDL-A had higher apoB concentrations than did 
persons with the LDL-B phenotype, suggesting that they may be 
predisposed to atherosclerosis. 
In addition, modified LDL has been isolated from 
atherosclerotic plaques on endothelial cells (Steinberg et 
al., 1989) and from plasma (Avogaro et al., 1988). The 
modification is initiated primarily by peroxidation of 
polyunsaturated fatty acids in the LDL lipids, as evidenced 
by the fact that LDL modification is inhibited by 
antioxidants such as vitamin E (Morel et al., 1984). During 
the oxidation process, there is extensive conversion of LDL 
phosphatidylcholine to lysophosphatidylcholine with fatty 
acid removal from the 2-position, indicating that the enzyme 
phospholipase Ag is related to the conversion (Parthasarathy 
et al., 1985). Smooth muscle cells (Morel et al., 1984), 
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monocytes, and macrophages (Parthasarathy et al., 1985) 
effect the modification of LDL. 
The fourth class of lipoproteins to be discussed is HDL. 
High-density lipoprotein are synthesized by hepatocytes 
(Hamilton et al., 1976) and enterocytes (Goldberg and 
Schonfeld, 1985). Nascent HDL particles are composed of a 
phospholipid bilayer disc with apoA-I and A-II and apoE 
incorporated into it and are the precursors of plasma HDL 
(Hamilton et al., 1976). It is thought that small amounts of 
apoC are also present (Ball and Man, 1986). Nascent HDL also 
can be formed during catabolism of the triacylglycerol-rich 
particles, VLDL and chylomicrons (Goldberg and Schonfeld, 
1985). These particles have a very high affinity for 
unesterified cholesterol, which is acquired from other 
lipoproteins, probably by surface exchange (Musliner et al., 
1988) or from plasma membranes of hepatic and extrahepatic 
cells (Despres et al., 1988; Knecht and Pittman, 1989). The 
free cholesterol on the outer surface of HDL then is 
esterified through a reaction with the enzyme LCAT and 
incorporated into the core of the HDL particle. Lecithin 
cholesterol acyltransferase is activated by apoA-I (Glomset 
and Norum, 1973). The result is a subspecies of HDL, the 
HDLg particle. Walsh and coworkers (1989) found that 
increased concentrations of apoA-I results in increased 
concentrations of HDL^ in transgenic mice. 
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High-density lipoprotein^ takes on other constituents as 
it circulates, including cholesterol from the sources 
mentioned above, as well as phospholipids and other soluble 
apolipoprbteins (Tall and Small, 1978). High-density 
lipoprotein^ conversion to the second subclass of HDL, HDLg, 
occurs from these actions as well as the continuing action of 
LCAT. High-density lipoproteing has the largest diameter of 
the HDL subspecies. Demacker et al. (1986) found that when 
HDL-cholesterol was relatively low, the majority of HDL was 
in the HDL^ form. With further increases in total HDL-
cholesterol, however, cholesterol was increasingly isolated 
in the HDLg fraction. 
ApoE, an apolipoprotein located on the HDL and VLDL 
particles, also plays a role in HDL metabolism. Several 
receptors on cell membranes recognize apoE as a ligand (Havel 
et al., 1987), including the LDL receptor. In addition, apoE 
may have other functions unrelated to lipid transport, 
including modulation of cell growth and differentiation 
(Mahley, 1988). As of yet, it is unknown if HDL uptake is 
entirely receptor mediated. There is definitely a receptor 
mediated portion of HDL uptake (Zsigmond et al., 1987; de 
Crom et al., 1989), but components of HDL, such as 
cholesterol and phospholipids, seem to be taken into cells 
more rapidly than do protein moieties of the particle (Karlin 
et al., 1987; Despres et al., 1988). 
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High-density lipoprotein has several functions. As 
stated, HDL has a role in triacylglycerol catabolism through 
interaction with lipoprotein lipase. High-density 
lipoprotein also has been implicated in having antithrombotic 
properties (Saku et al., 1985). Lastly, HDL has a major role 
in transport of cholesterol from peripheral tissues to liver 
for excretion, primarily through formation and secretion of 
biliary bile acids and secretion of biliary cholesterol, 
during the process termed reverse cholesterol transport 
(Norum et al., 1983). 
Reverse cholesterol transport is initiated when 
cholesterol-laden cells, such as macrophages (as foam cells) 
or extrahepatic tissues, release cholesterol. Phospholipid-
rich HDL that contains no apoE acts as a cholesterol 
acceptor. As the HDL collects cholesterol from tissues and 
other lipoproteins, it acquires apoE. The presence of apoE 
actually may facilitate incorporation of cholesterol into the 
HDL particle. These cholesterol-rich HDL particles then 
transport the cholesterol collected from tissues to the liver 
where HDL can be taken up by the LDL receptor. In addition, 
in humans and some animal species, there is a transfer of 
cholesteryl esters from HDL to LDL, VLDL, IDL, and tissues 
via cholesteryl ester transfer proteins (possibly 
apolipoprotein D, apoD). The lower density lipoproteins then 
can be taken up by the liver through receptor-mediated uptake 
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(Mahley, 1988). A portion of the cholesterol received by 
liver ultimately is secreted into bile as bile acids and 
biliary cholesterol (Kashyap, 1989). 
Another lipoprotein class, lipoprotein (a) or Lp(a), has 
been discovered and now is being studied extensively. 
Lipoprotein (a) is described as a particle distinct from LDL, 
although its density is approximately 1.04 g/mL, that 
contains apoB^QQ and binds to the LDL receptor (Morrisett et 
al., 1987). The primary difference between Lp(a) and LDL is 
that Lp(a) contains a carbohydrate-rich polypeptide that 
binds covalently by disulfide bridges to apoB^gg, making the 
particle larger and more dense than usual (Packard and 
Shepherd, 1987). The structure of Lp(a) is similar to that 
of plasminogen and may bind to sites for plasminogen on 
fibrin (Uterman, 1989), thereby affecting clot dissolution. 
High concentrations of Lp(a) have been associated with human 
cardiovascular disease (Morrisett et al., 1987). In baboons, 
the plasma concentration of Lp(a) is controlled primarily 
through inheritance rather than by diet (Rainwater et al., 
1989). 
Postprandial lipoprotein metabolism \ 
Because humans eat regularly spaced meals, they are 
predominantly in a postprandial state throughout most of the 
day. Most research studies on lipoprotein metabolism. 
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however, have been designed to be carried out in the fasting 
state to improve reproducibility of assays and to establish 
and compare metabolic baselines. Major changes occur in 
constituents of lipoproteins and rates of metabolism of these 
constituents after a meal, especially a meal containing a 
relatively high amount of fat. Additional research on 
postprandial lipoprotein metabolism needs to be completed 
because the pertinent data are sparse and also because 
postprandial changes in lipoprotein composition have been 
implicated in changing lipoprotein atherogenicity 
(Zilversmit, 1979). 
Compositional changes in plasma lipoproteins after a 
fatty meal include an increase in chylomicron and VLDL number 
and diameter of individual particles because of increased 
triacylglycerol and cholesterol ester concentrations. 
Relative concentrations of apoE and C also increase; however, 
concentrations of apoA-I and A-IV seem to be depleted (Tall, 
1986). In LDL, cholesteryl esters may decrease slightly 
postprandially, but generally LDL composition changes only 
slightly (Cohn et al., 1988). High-density lipoprotein 
composition generally changes after a meal containing dietary 
fat. An increase in phospholipid and protein content of HDL 
has been seen by some researchers (Groot and Scheek, 1984), 
but no change in the concentration of these constituents has 
been noted by others (Cohn et al., 1988). Concentration of 
25 
cholesteryl esters in HDL has been reported to increase (Tall 
et al., 1982), decrease (Cohn et al., 1988), and be unchanged 
(Havel et al., 1973) in different studies. Relative 
concentrations of triacylglycerol in HDL tend to increase 
with increased plasma triacylglycerol (Tall, 1986). 
After ingestion of a meal containing dietary fats, there 
is a postprandial increase in plasma triacylglycerols as a 
result of increased secretion of chylomicrons from the 
intestine (Bisgaier and Glickman, 1983). The 
triacylglycerols are hydrolyzed from the particles by 
lipoprotein lipase and are taken up by peripheral tissues, 
leaving chylomicron remnants. These remnants are thought to 
be cleared from plasma by receptors specific for apoE (Jones 
et al., 1984). Some investigators, however, hypothesize that 
surface fragments (phospholipid, apoA-I, and A-II) of the 
triacylglycerol-rich lipoproteins fuse with existing serum 
HDLg particles to form HDLg particles (Groot and Scheek, 
1984). Conversely, apoE, apoC, and cholesteryl esters are 
transferred from HDL to chylomicron remnants (Tall et al., 
1982) ; cholesteryl ester movement in humans probably is 
facilitated by transfer proteins (Mahley, 1988). Therefore, 
concentration and type of HDL present may affect metabolism 
and ultimate clearing of chylomicron remnants. Because 
chylomicron remnants are atherogenic (Zilversmit, 1979; Van 
Lenten et al., 1985), the protective role of HDL may be to 
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accelerate chylomicron remnant clearing in addition to 
participating in reverse cholesterol transport. 
Several factors can affect composition of postprandial 
lipoproteins, including age and sex of individuals (Cohn et 
al., 1988), fasting concentration of plasma cholesterol 
(Fielding et al., 1989), plasma triacylglycerol concentration 
(Olefsky et al., 1976), and possibly type of dietary fat and 
amount of dietary fat and cholesterol (Olefsky .et al., 1976; 
Kashyap et al., 1983; Groot et al., 1988). Groot and 
coworkers (1988) fed diets that were rich in either sunflower 
seed oil or palm oil to rats. Those rats fed palm oil 
developed higher concentrations of plasma VLDL and therefore 
higher concentrations of plasma triacylglycerol 
postprandially than did rats fed sunflower seed oil. The 
difference in VLDL concentration was not because of hepatic 
secretion rate but because of differences in plasma 
triacylglycerol catabolism rates between rats fed the two 
diets, with rats fed palm oil having slower VLDL-
triacylglycerol catabolism than rats fed sunflower seed oil. 
In addition, rats fed sunflower seed oil tended to develop 
higher concentrations of plasma lipoprotein lipase. However, 
Kashyap et al. (1983) found that the polyunsaturated to 
saturated fatty acid ratios of the diet did not significantly 
influence triacylglycerol catabolism in plasma. 
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Atherosclerosis 
The earliest observable lesion of atherosclerosis is the 
fatty streak. Fatty streaks cover approximately 10% of the 
aortic intimai lining as early as 10 years of age in humans 
(McGill, 1968). Fatty streaks are aggregates of 
subendothelial foam cells, primarily of macrophage origin, 
but with a small proportion of cells being derived from 
smooth muscle cells. Grossly, fatty streaks are slightly 
raised, yellowish in color, and longitudinally oriented in 
the vessels. They have little extracellular lipid (Agel et 
al., 1985). In general, fatty streaks are ubiquitous within 
the human population, and most are harmless or regress 
completely. However, in some individuals or in some 
anatomical locations (i.e., coronary arteries), the fatty 
streaks may progress to fibrous or fibrofatty plaques, the 
next stage of atherogenic plaque development (Munro and 
Cotran, 1988). 
The fibrofatty plaque is the primary lesion in 
atherosclerosis because it causes narrowing and occlusion of 
the artery and increases the likelihood of thrombosis. 
Plaques are usually rounded, raised, and off-white in color. 
Larger plaques contain a center filled with clotted, 
yellowish fluid for which the plaques were originally named 
(athero-, meaning gruel in Greek). A typical lesion contains 
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a fibrous cap consisting primarily of smooth muscle and dense 
connective tissue containing elastin, collagen, 
proteoglycans, and a basement membrane (Kramsch et al., 
1971); a cellular area beneath and surrounding the cap that 
consists of macrophages, smooth muscle cells, and T 
lymphocytes (Jonasson et al., 1986); and a deep "necrotic 
core" that contains extracellular lipid droplets, calcium 
deposits, crystalline cholesterol, and cellular debris. The 
core also has a relatively large population of foam cells 
from both macrophage and smooth muscle cell origin. In 
addition, small, newly formed blood vessels occasionally 
surround the lesion (Munro and Cotran, 1988). 
Plaque distribution is not random but is generally 
defined in location. The most common site of plaque 
formation is in the lower descending aorta, primarily at 
arterial branch points. The second most common site of 
plaque formation is the coronary arteries, followed by 
arteries of the legs, the descending thoracic aorta, and the 
internal carotid arteries (Munro and Cotran, 1988). The 
heterogeneity among persons with atherosclerotic disease is 
huge and follows no defined pattern. For example, a person 
with plaques in the coronary artery may have no 
atherosclerosis in the aorta or vice versa. 
Theories trying to explain the causes of initiation and 
progression of atherosclerotic plaques abound. None of the 
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theories can explain every aspect of atherosclerotic plague 
formation, and, because of the complexity of the disease, 
many factors play a role in plague development; so at least 
portions of all the theories may be correct. Steinberg 
(1983) suggests that familial hypercholesterolemic persons, 
those with defective LDL receptors that are nonfunctional and 
so cause extremely high blood LDL-cholesterol concentrations, 
are adequate examples to demonstrate that elevated blood LDL-
cholesterol concentration alone is enough to cause initiation 
and progression of atherosclerosis. 
On the other hand, Ross (1986) suggests the "response-
to-injury" hypothesis. This hypothesis proposes that, in the 
very early stages of atherogenesis, the endothelium of the 
vessels become injured, allowing cells to separate, 
desquamate, or become altered in several ways. Because the 
vessel wall is "denuded", platelets and monocytes adhere to 
it. These cells then secrete chemoattractants for smooth 
muscle cells; consequently, smooth muscle cells migrate into 
the area from deeper in the vessel wall. Adhered platelets 
release platelet-derived growth factor (PDGF) which further 
induces division and growth of smooth muscle cells (Bowen-
Pope et al., 1982). In addition, monocytes release 
macrophage-derived growth factor, a factor that is also 
mitogenic for smooth muscle cells (Leibovich and Ross, 1976). 
Smooth muscle cell proliferation is accompanied by lipid 
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accumulation (both intra- and extracellular) and increased 
synthesis of connective tissue. Injuries to the endothelial 
lining are thought to be caused by turbulent blood flow, 
especially at the arterial bifurcations, by mechanical injury 
(Ku et al., 1985), or by biochemical and physiological 
changes, such as elevated LDL-cholesterol concentrations 
(Steinberg, 1983). 
In contrast, Benditt and Benditt (1973) suggest that 
smooth muscle cell proliferation because of cellular 
mutation, not injury, is the initiating event in 
atherosclerosis. They conclude that the fibrofatty plaque 
has a monoclonal origin and is not likely to result from 
cellular injury and subsequent proliferation because a 
phenomenon such as this would be polyclonal in origin. 
Campbell et al. (1985) hypothesize that smooth muscle cells 
have three different phenotypes: (1) a nonproliferative, 
contractile cell filled with myofilaments (a physiologically 
normal smooth muscle cell), (2) a cell that is "reversibly 
synthetic" and filled with Golgi apparatus, rough endoplasmic 
reticulum, and free ribosomes, and (3) "irreversibly 
synthetic" cells that respond to mitogens and have had five 
or greater replications. The latter class of cells may have 
increased ability to respond to cellular injury or 
hyperlipidemia and so are better able to take up ^ -VLDL and 
accumulate lipid to form foam cells. 
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An area of concentrated study in atherosclerosis 
research at the present time is the role of monocytes and 
macrophages in initiation and progression of plagues. After 
hypercholesterolemia is induced dietarily in many animal 
models, there is a migration of monocytes to the arterial 
wall with subseguent conversion to foam cells (Joris et al., 
1983; Gerrity, 1984). Monocytic adherence to arterial walls 
may be because of an inflammatory stimulus, 
hypercholesterolemia causing endothelial modification, 
chemoattractants, or excessive lipoproteins functioning as 
ligands for monocytes and endothelial cells (Clarke et al., 
1987). Macrophages participate in the atherogenic process in 
many ways, including ingestion of circulating lipoproteins 
(Brown and Goldstein, 1983), synthesis and secretion of 
lipoprotein lipase (Mahoney et al., 1982), hydrolysis and 
reesterification of cholesteryl esters (Brown et al., 1980), 
secretion of apoE (Takemura and Werb, 1984), secretion of 
different growth factors (Nilsson, 1986), and secretion of 
proteolytic enzymes (Werb, 1983). 
Macrophages take up lipids by way of scavenger 
receptors. Generally, modified LDL bind to the macrophage 
and are internalized by this receptor pathway. Macrophages 
also contain a second LDL receptor mechanism that is specific 
for native LDL and that can be induced in cell culture by 
incubation with LDL-depleted media (Traber and Kayden, 1980). 
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Scavenger receptors, however, are not regulated by cellular 
cholesterol concentration (Goldstein et al., 1980). 
Platelets and macrophages can secrete many different 
factors (primarily protelnaceous) that Increase smooth muscle 
cell proliferation, monocyte adherence to vessel walls, and 
vascular endothelial cell permeability. These factors 
Include PDGF, epidermal growth factor, and transforming 
growth factor-# (TGF-/3) from platelets and Interferon o, 
prostaglandin , TGF-#, Interleukin I, PDGF, fibroblast 
growth factor, and tumor necrosis factor from the 
monocyte/macrophage (Munro and Cotran, 1988). 
Genetic and environmental variation provide a milieu of 
conditions conducive to atherosclerosis. Environmental 
factors include diet, smoking, stress, exercise, and other 
controllable and uncontrollable factors. The effect of diet 
on atherosclerosis will be discussed in a later section. 
There is also a genetic component to atherosclerotic disease. 
Nora et al. (1980) reported a heritabillty of 0.63 for 
coronary artery disease in families that had early onset of 
atherosclerosis. A large proportion of this phenomenon may 
be caused by heritabillty of apolipoproteln structural 
modifications. Recently, use of recombinant DNA techniques 
have increased knowledge of the location and structure of the 
apolipoproteln genes. Apolipoproteln genes are found on 
chromosomes 1, 2, 11, and 19, and there is considerable 
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sequence homology among them (Breslow, 1985; Luo et al., 
1986). 
In contrast, Clarke et al. (1987) suggested that the 
multiple functions of macrophages may be the mechanism 
causing polymorphism in human atherosclerosis. Research into 
the genetics of atherosclerosis may allow screening and 
identification of individuals in infancy who are prone to 
this disease. 
Recently, Lp(a) apolipoproteins and antigens were cloned 
and studied. Lipoprotein (a) concentration is highly 
heritable (Berg, 1989) and exhibits large similarities to 
plasminogen (Brown and Goldstein, 1987). Work on Lp(a) may 
provide the link with atherosclerosis and the coagulation 
system of the body that has been sought for years. 
In addition to the link of atherosclerosis to the 
coagulation system, atherosclerosis also has been linked to 
viral infection (Cunningham and Pasternak, 1988) and to the 
immune system (Hansson et al., 1989). Clearly, 
atherosclerosis is a multifactorial disease with many avenues 
of initiation and progression. 
Because atherosclerosis is so widespread and insidious, 
most research focuses on its prevention, initiation, and 
progression. However, another important facet of 
atherosclerosis research must be considered, i.e., atheroma 
regression. Experimental atherosclerotic lesions have been 
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regressed in rhesus monkeys when their nutrition was changed 
from a high cholesterol diet to a low cholesterol diet (Eggen 
et al., 1987). Regression of plagues by means other than 
diet also have been noted in chicks (Pick et al., 1952), 
pigeons (Subbiah et al., 1978), rats (Morin et al., 1964), 
and humans (Barndt et al., 1977). Raffenbeul et al. (1979) 
reported that regression of plaques in coronary arteries 
occurred in only approximately 20% of cases in patients with 
established coronary heart disease. Age also may affect 
reverse cholesterol transport. A review by Kashyap (1989) 
reported that serum from young mice was much more effective 
in removing cholesteryl esters from HDL to recipient 
lipoproteins than was serum from older mice in cell culture, 
thus speeding reverse cholesterol transport. Regression of 
lesions probably is mediated primarily by reverse cholesterol 
transport as discussed previously, but other mechanisms 
almost certainly play some role in regression. 
Diet and Cholesterol Metabolism 
Dietary cholesterol 
The effects of dietary cholesterol on plasma 
concentrations of cholesterol have been examined extensively, 
yet results are equivocal. Much research has been done using 
animal models for humans, but it has become evident that 
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different species of animals respond differently to increases 
in cholesterol intake. In addition, there is a huge inter-
individual variation within a given species, including 
humans. Individuals that respond to increases in dietary 
cholesterol have been termed hyperresponders, and those whose 
blood concentrations of cholesterol are not affected are 
termed hyporesponders (Beynen et al., 1986). Possible 
mechanistic differences between these two groups of 
individuals will be discussed. Extensive reviews of the 
relationship of dietary cholesterol to serum cholesterol 
concentrations were done by McGill (1979) and Grundy (1983). 
Animal species that respond to increased intakes of 
dietary cholesterol with increases in plasma cholesterol 
concentration include rabbits (Wang et al., 1957), chickens, 
guinea pigs, calves, obese Zucker rats (Terpstra and Beynen, 
1984), and some nonhuman primate species (Teramoto et al., 
1987). Species that are, in general, hyporesponders are rats 
(Wilson, 1964) and mice (Terpstra and Beynen, 1984). Rats 
have the ability to compensate for high dietary intakes of 
cholesterol by decreasing cholesterol synthesis and 
concurrently increasing bile acid synthesis (Morris et al., 
1957; Wilson, 1964). Some animal species seem to respond to 
high cholesterol diets with increased serum cholesterol 
concentrations only under certain dietary conditions. For 
example, swine fed high fat diets supplemented with 
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cholesterol developed hypercholesterolemia, decreased 
cholesterol synthesis, and decreased excretion of biliary 
lipids compared with their counterparts fed a low fat, high 
cholesterol diet (Reiser et al., 1959). These effects may be 
mediated through increased or decreased cholesterol 
absorption rates. 
Many researchers have shown the existence of hypo- and 
hyperresponders within a species of animal. Monkeys show a 
broad individual responsiveness to dietary cholesterol within 
a species (Clarkson et al., 1971; Eggen, 1976). Rats (Van 
Zutphen and den Biemen, 1981), rabbits (Van Zutphen and Fox, 
1977), and pigeons (Wagner and Clarkson, 1974) have shown a 
similar phenomenon. From studies such as these, evidently a 
major part of individual variation within a strain or species 
is because of genetic differences (Beynen et al., 1986). 
It seems that humans, as well, have individual variation 
and can be categorized as either hypo- or hyperresponders. 
McGill's review (1979) reports research results from several 
studies showing variability in individual responses. The 
differences in response seen in animals and humans may be 
because of physiological differences in cholesterol 
absorption, regulation of the LDL receptor,.synthesis of 
cholesterol in the liver or other organs, or biliary 
excretion rates. 
The amount of dietary cholesterol a human absorbs is the 
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subject of much debate. Estimates range from 30% (Grundy and 
Mok, 1977) to 60-80% (Mok et al., 1979). Several factors can 
affect absorption of cholesterol, including size of the bile 
acid pool, because bile acids are required for cholesterol 
absorption. Other factors may include intestinal transit 
time, amount of pancreatic lipase secreted, deficiency of 
esterifying enzymes in the intestinal mucosa, and several 
dietary factors (i.e., type and amount of dietary fat) 
(Grundy, 1983). Quintao et al. (1971) showed that up to 1 
gram of cholesterol can be absorbed per day in men fed 3 
grams of cholesterol. McGill (1979) reviewed several 
experiments that suggest that the average concentration of 
serum cholesterol increases with increasing dietary 
cholesterol when total intake is 0-600 mg/day, but intakes 
over 600 mg/day produce little, if any, additional increase 
in plasma cholesterol concentration; the "break value" of 600 
mg/day tends to increase if the. diet is relatively high in 
saturated fatty acids, possibly because of increased 
absorption of cholesterol. 
Another difference in individuals may be the ability of 
the body to down-regulate the LDL receptor in response to 
dietary cholesterol that has been absorbed. Applebaum-Bowden 
et al. (1984) suggested that diets containing 1,034 mg/day of 
cholesterol caused a down-regulation of LDL receptors, 
primarily because of an increase in plasma LDL-cholesterol 
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concentrations. Similar results were shown by Kovanen et al. 
(1981b). Belatedly, individuals may differ in their inherent 
ability to down-regulate synthesis of cholesterol. Quintao 
and others (1971) showed that "the amount of suppression in 
synthesis was extremely variable" between subjects. 
Bhattacharyya and Eggen (1987) suggest that rhesus monkeys 
that do not respond to dietary cholesterol with increased 
serum cholesterol concentration (low responders) may have the 
ability to decrease in vivo synthesis of cholesterol, but 
high responders do not. 
The last mechanism to be discussed that may control 
hypercholesterolemic responses to high intakes of dietary 
cholesterol is biliary secretion of lipids and subsequent 
loss into the feces as acidic and neutral sterols. This is 
the primary mechanism to explain why rats do not respond to 
high cholesterol diets with increased plasma cholesterol 
concentration (Wilson, 1964). In humans, however, 
cholesterol excretion via bile seems to be a secondary 
response mechanism when compared with decreased cholesterol 
synthesis (Maranhao and Quintao, 1983). Maranhao and Quintao 
(1983) concluded that, whenever absorption of cholesterol 
suppressed the ability of several compensatory mechanisms, 
body cholesterol accumulation occurred in an amount 
proportional to the amount absorbed. 
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Dietary fats 
A tremendous amount of research has been published on 
.the effects of dietary fats and fatty acid compositions on 
blood lipids and atherosclerosis. In general, 
polyunsaturated fats come from plant sources whereas 
saturated fats come from animal and tropical plant (i.e., 
coconut and palm oil) sources. In 1957, Keys and coworkers 
suggested that, for most dietary fats, reasonable estimates 
of the change in plasma cholesterol concentration in humans 
fed the diet could be made from data on the percentage of 
calories obtained from saturated and polyunsaturated fatty 
acids. The formulae derived from Keys' work suggest that 
saturated fatty acids raise the concentration of cholesterol 
in plasma two times more than polyunsaturated fatty acids 
lower it. Monounsaturated fatty acids were considered 
neutral. Studies in several animal species show a rise in 
plasma cholesterol concentration when saturated fatty acids 
are fed and decrease when polyunsaturated fatty acids are fed 
(Vega et al., 1982; McNamara, 1987; Oliver, 1987). This 
effect probably does not alter lipoprotein composition but 
decreases VLDL and LDL apoB production rates (Vega et al., 
1982) . 
In 1965, Keys and associates refined their predictions 
because certain dietary fats did not seem to "fit" the 
equations. Analyses indicate that stearic acid (C18:0) and 
40 
saturated fatty acids having fewer than 12 carbon atoms have 
little effect on serum cholesterol concentration in humans. 
Dietary fats that are high in concentration of stearic acid 
or short-chain saturated fatty acids include tallow and cocoa 
butter. Bonanome and Grundy (1988) compared feeding of high 
concentrations of stearic acid with high concentrations of 
palmitic acid. Total plasma cholesterol fell 14% in patients 
fed the stearic acid-rich diets; LDL-cholesterol fell 21%. 
Since Keys' article in 1965, subsequent research also has 
shown that different polyunsaturated fats may have different 
effects, especially when comparing n-3 and n-6 fatty acids 
(Illingworth et al., 1984). The debate also continues as to 
the role of monounsaturated fatty acids in control of plasma 
cholesterol concentration. 
Plasma lipoproteins also seem to be affected 
differentially by dietary fats, which is an important fact 
because high concentrations of LDL are associated with 
increased risk of CHD. A high concentration of HDL is 
thought to be protective against atherosclerosis. 
Incorporation of large amounts of polyunsaturated fatty acids 
into the diet not only decreased LDL-cholesterol 
concentration but HDL-cholesterol concentration as well 
(Shepherd et al., 1978; Vaziri et al., 1988). Others, 
however, did not see this effect (Mattson and Grundy, 1985). 
In addition, some research showed no effect of dietary fat 
41 
source on plasma cholesterol concentration (Howard et al., 
1965; Walsh et al., 1983). 
Monounsaturated fatty acids, especially oleic acid, have 
been receiving much attention recently. In 1959, Keys et al. 
suggested that oleic acid was neutral in effect on plasma and 
LDL-cholesterol concentration. However, Mattson and Grundy 
(1985) found oleic acid to be as effective as linoleic acid 
in decreasing concentration of LDL-cholesterol in 
normolipemic patients. In addition, epidemiological studies 
suggest a similar trend because persons that ingest large 
amounts of olive oil (high in oleic acid), such as those in 
Mediterranean regions, have relatively lower incidence of CHD 
(Keys, 1970). Ellsworth et al. (1986) found that liver 
preparations grown in media containing relatively high 
amounts of oleic acid had decreased LDL and increased VLDL 
secretion from the liver. 
Fish oils and other dietary fats that are rich sources 
of n-3 fatty acids also have received attention recently. In 
general, vegetable oils have primarily n-6 fatty acids, that 
is, the first double bond is at carbon number 6 if counting 
from the methyl end of the fatty acid. Fish oils generally 
contain a much larger proportion of n-3 fatty acids. Fish 
oils have been shown to decrease VLDL and LDL synthesis 
(Illingworth et al., 1984) and suppress hepatic cholesterol 
synthesis (Ventura et al., 1989). Some studies also have 
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shown a decrease in HDL-cholesterol as well as LDL-
cholesterol when feeding fish oils (Bradlow et al., 1983; 
Harris et al., 1983) In addition, a study using rabbits 
showed fish oil to have no effect on LDL-, HDL-, or VLDL-
cholesterol concentrations (Campos et al., 1989). Fish oil 
ingestion may have side effects as well, including increased 
bleeding time, decreased platelet aggregation, and decreased 
platelet thromboxane Bg production (Saynor et al., 1984). 
Several reviews have been presented on the effects of dietary 
fish oil on blood lipids and CHD (Fisher et al., 1989; 
Harris, 1989). 
The effects of different fat sources on biliary 
metabolism is discussed in the section on bile. 
Dietary fatty acids can be incorporated to a large 
extent into body tissues of most monogastrics, including 
pigs, which may cause physiological changes in the animal, 
such as changes in lipoprotein metabolism and membrane 
structure and function. Baldner-Shank et al. (1987) found 
that pigs fed soy oil had greater cholesterol concentration 
in the heart, skeletal muscle, and viscera than did pigs fed 
beef tallow. In these pigs, plasma cholesterol varied 
reciprocally with cholesterol in several tissues. Other 
researchers, as well, have shown that dietary fat composition 
can alter cholesterol concentration in several tissues (Walsh 
et al., 1983; Diersen-Schade et al., 1984; Diersen-Schade et 
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al., 1986), including increased uptake of cholesterol into 
liver when polyunsaturated fats were fed (Vaziri et al., 
1988). The effect of accumulation of cholesterol in liver 
may account partially for the apparent hypocholesterolemic 
effect of polyunsaturated fats relative to saturated fats. 
The scenario displayed above may be a protective 
mechanism for the cell membrane because increased cholesterol 
in the membrane would decrease membrane fluidity (Oldfield 
and Chapman, 1972), whereas an increased proportion of 
polyunsaturated fatty acid incorporation into the cell 
membrane would increase membrane fluidity. In contrast, 
however, Kramer (1980) and Farnworth and Kramer (1987) found 
that only the concentration of monounsaturated fatty acids in 
the cell membrane phospholipids could be influenced to a 
great extent by dietary fat source in rats. Hamm et al. 
(1988) indicated that arachidonic acid, unlike other 
polyunsaturated fatty acids, is maintained at a constant 
concentration in cell membranes. Therefore, linoieic and 
linolenic acids may be the primary causes for the 
hypocholesterolemic response seen in subjects with high 
intakes of plant sources of polyunsaturated fatty acids. 
Cell membrane composition, structure, and fluidity can 
affect several aspects of cell membrane function. The 
structural part of the cell membrane is the lipid phase. It, 
therefore, is logical to assume that cell membrane 
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composition influences membrane permeability, fusion, and 
activity of membrane-bound proteins. Many experiments have 
shown that the function of membrane-bound protein can be 
influenced by type of fatty acid incorporated into 
phospholipid. For example, endoplasmic reticulum Ca^^-ATPase 
has optimal activity when membrane phospholipids contain 
fatty acids with 20 carbon atoms (Johannsson et al., 1981). 
This observation may indicate an optimal bilayer thickness. 
Fatty acid saturation probably plays a key role as well in 
membrane function. Several membrane enzymes can be regulated 
by lipid content of cell membranes (Sandermann, 1978), and so 
it is probable that protein receptors on cell membranes can 
be regulated in this way as well. 
Researchers have shown that LDL receptor function and 
gene expression can be mediated by dietary fat, presumably by 
changes in membrane composition. Baboons fed coconut oil, 
which is rich in saturated fatty acids, had a lower mRNA 
concentration for the LDL receptor protein in the liver than 
did those fed a diet high in polyunsaturated fats (peanut 
oil) or a diet high in monounsaturated fats (olive oil) (Fox 
et al., 1986). Dietary coconut oil also caused lowered 
receptor-dependent LDL transport across liver membranes in 
hamsters; in addition, increased amounts of dietary 
cholesterol decreased receptor-dependent LDL transport to an 
even greater extent in these hamsters (Spady and Dietschy, 
1988) . 
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Other dietary factors 
Although dietary fats probably have the greatest impact 
on body cholesterol content and lipoprotein metabolism, other 
dietary factors can play a role as well. This fact makes 
recommendations about dietary control of plasma cholesterol 
concentrations a complicated issue. 
Generally, dietary proteins from plant sources are 
thought to be hypocholesterolemic but proteins from animal 
sources are thought to be hypercholesterolemic. However, 
there is a tremendous species variation associated with this 
phenomenon, making it very difficult to extrapolate 
recommendations for humans from animal models (Foley et al., 
1988)•• This is a very controversial issue at the present 
time. 
Dietary fiber also has received much attention recently. 
It is believed that soluble fibers are hypocholesterolemic 
whereas insoluble fibers have little or no effect on control 
of serum cholesterol and lipoprotein metabolism (Kritchevsky 
and Beynen, 1986). Simple dietary carbohydrates, such as 
sucrose and fructose, were found to be atherogenic in rabbits 
and baboons when they replaced starch in the diet. Human 
studies are not consistent, but some show an increase in 
concentration of cholesterol in serum in response to 
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substitution of sucrose for either starch or glucose (Story, 
1982). 
Several vitamins and minerals have been implicated in 
alterations of lipoprotein metabolism as well. Our 
laboratory has completed research on the effects of calcium 
and vitamin D on plasma lipids and atherosclerosis in pigs 
and goats. Foley et al. (1990) found that excess calcium and 
cholecalciferol had no effect on plasma or lipoprotein 
cholesterol concentration after four weeks of feeding in 
young pigs. In contrast, Hines et al. (1985) found that 
excess cholecalciferol caused atherosclerosis in young goats. 
Other minerals that have been implicated in atherosclerosis 
prevention include optimal amounts of sodium, magnesium, 
chromium, copper, zinc, and iodine salts. Atherosclerosis 
progression may be exacerbated by deficiencies of chromium, 
iron, copper, zinc, selenium, and iodine salts (review by 
Mertz, 1982). 
Obviously, a complete comprehensive review of the 
effects of diet on cholesterol and lipoprotein metabolism 
would be impossible because of the plethora of published 
research results available. Yet, with all of the combined 
research, exact effects and interactions of all dietary 
components on cholesterol metabolism and atherosclerosis 
remain equivocal and debate among scientists remains strong. 
Consequently, dietary recommendations are difficult to make. 
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but continued research should make this job easier. 
Bile 
Bile composition 
Bile is the major excretory route of cholesterol from 
the body through both bile acids and biliary cholesterol. 
Obviously then, research on cholesterol metabolism must 
include an understanding of biliary secretion, formation, 
function, and composition, as well as an understanding of how 
factors that have been shown to alter blood cholesterol 
concentration affect bile metabolism. 
Bile is composed primarily of water, bile acids, 
cholesterol, and phospholipids (the majority is 
phosphatidylcholine) but does contain many other constituents 
as well. Ions contained in bile include those of calcium 
(Rege et al., 1987), sodium, and hydrogen, as well as 
chloride and bicarbonate (Reuss, 1989). Bile also contains 
bilirubin, a major byproduct of hemoglobin catabolism, which 
gives bile its characteristic yellowish color. The important 
consideration of bilirubin concentration in the bile stems 
from the fact that bilirubin is a major constituent of 
pigment gallstones in humans (Rege et al., 1988). 
Proteins are the third most prevalent solid in bile with 
5% of solids in bile being from biliary protein (bile acids. 
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63%; cholesterol, 3%; phospholipids, 20%; and bilirubin, 1%; 
Holan et al., 1979). Many of the proteins in bile are 
derived from plasma or from liver cells, either directly or 
indirectly, via microsomal uptake and transport. The exact 
function of these proteins in bile is unknown. Proteins may 
be in bile because of degradative or disposal mechanisms of 
the hepatocytes or they may have specialized functions that 
are, as of yet, unknown. Of particular interest is the 
presence of secretory IgA and apolipoproteins AI, All, and B 
in bile. In addition, certain proteins in bile may be 
indicative of a disease state, such as the presence of 
gallstones, inflammation, or certain liver disorders 
(LaRusso, 1984). In addition, bile mucin, a high molecular 
weight glycoprotein found in bile, has been implicated as 
important for the initiation and formation of gallstones 
(Smith, 1987). 
Recently, Renaud et al. (1989) discovered that bile is 
one of the final recipients of hepatic lysosomal contents in 
rats. This is thought to occur via exocytosis of lysosomes 
from hepatocytes into bile canaliculi. By utilization of 
colloidal gold particles that had been taken up into 
lysosomes, Renaud and coworkers (1989) determined that as 
much as 25-30% of the daily turnover of lysosomal enzymes by 
rat liver is accounted for by biliary excretion. The authors 
theorize that this process would decrease the need for liver 
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cells to destroy or process the filled lysosomal bodies and 
thus save energy that would be expended on this cellular 
event. In addition, this may be an important pathway of 
disposal of partially degraded, undegraded, or undegradable 
products that could accumulate in lysosomal vesicles. 
The other solid constituents of bile are the biliary 
lipids, which include bile acids, biliary cholesterol, and 
phospholipids. Bile acid synthesis has an absolute 
requirement for cholesterol and occurs exclusively in the 
liver microsomes (Danielsson and Sjovall, 1975). Bile acid 
synthesis proceeds by hydroxylation of the cholesterol 
molecule at carbons 3, 7, and 12, saturation between carbons 
5 and 6, removal of carbons 25, 26, and 27, and conversion of 
carbon 24 to a carboxyl group (Goswami and Dupont, 1982). 
Individual bile acids differ from one another in the 
number, position, and stereochemistry of the hydroxyl groups. 
These differences allow designation of the bile acids as 
either a- or ^ -configuration. Primary bile acids are those 
synthesized in the liver cell; in contrast, secondary bile 
acids are formed from conversion of the primary bile acids by 
intestinal microorganisms. Free bile acids are conjugated 
with glycine and. taurine in approximately equal amounts in 
the liver microsomes to decrease toxicity of the free bile 
acids (Goswami and Dupont, 1982). 
The two most abundant bile acids in humans are cholic 
50 
acid and chenodeoxycholic acid (Goswami and Dupont, 1982). 
Porcine bile, however, contains a large proportion of 
hyocholic acid, a bile acid that is hydroxylated at carbon 6 
rather than carbon 7 as is cholic acid. Porcine bile, like 
human bile, also contains a relatively large proportion of 
chenodeoxycholic acid. These bile acids are conjugated 
primarily with glycine; however, taurine conjugates do occur 
(Haslewood, 1964). Bostrum (1986) determined that the 6a-
hydroxylation that occurs to form hyocholic acid is 
microsomal and is catalyzed by cytochrome P450-dependent 
systems, as is synthesis of all other primary bile acids in 
all mammals examined to date. 
The preferred source of cholesterol for bile acid 
synthesis and for biliary cholesterol secretion seems to be 
certain pools of hepatic cholesterol. Turley and Dietschy 
(1981) found that newly synthesized, nonesterified 
cholesterol was the preferred source for biliary cholesterol 
in rats. Robins et al. (1985) had similar findings and 
suggested that newly synthesized cholesterol originates from 
the interior of the hepatocyte and that this location of 
synthesis may be the reason for preferential secretion of 
newly synthesized cholesterol into bile. 
The preferred source of cholesterol precursors for bile 
acids is found in certain hepatic cholesterol pools. Several 
researchers have suggested that newly synthesized cholesterol 
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is the preferred substrate for bile acid synthesis 
(Mitropoulos et al., 1974; Bjorkhem and Lewenhaupt, 1979). 
Similar results have been found with precursor pools to the 
first committed step in bile acid synthesis (7a-
hydroxylation) in that this enzyme preferentially uses newly 
synthesized cholesterol (Balasubramaniam et al., 1973). In 
addition, biliary cholesterol seems to arise from a different 
pool than does cholesterol used to synthesize bile acids 
(Cronholm et al., 1974). In contrast, Kim and coworkers 
(1975) suggest that the precursor for bile acid synthesis in 
swine is a mixture of dietary and endogenously synthesized 
cholesterol. 
There also is a difference in source of preformed 
cholesterol for bile acid synthesis. High-density 
lipoprotein-cholesterol in the free form is the preferred 
source of biliary sterols (Halloran et al., 1978; Schartz et 
al., 1981; Scobey et al., 1989). Scobey et al. (1989) 
hypothesized that HDL-free cholesterol enters a hepatic 
compartment that communicates more readily with precursor 
pools than with other pools, whereas HDL-esterified 
cholesterol seems to mix with all liver pools with equal 
efficiency. In addition, free cholesterol from HDL and LDL 
in monkeys seems to be incorporated most readily into cholic 
acid rather than into chenodeoxycholic acid (Stephen and 
Hayes, 1985). Bile acid synthesis is down-regulated by 
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normal reabsorption of bile acids from the intestine and 
subsequent transport to the liver (Danielsson and Sjovall, 
1975; Hall et al., 1988). 
Physiology and metabolism of bile 
Bile is formed continually in small amounts by 
hepatocytes. It is secreted from the liver cells into bile 
canaliculi that lie between cells. The bile in bile 
canaliculi empties into terminal bile ducts, then to 
progressively larger ducts, and finally to the right and left 
hepatic ducts. The hepatic ducts join to form the common 
hepatic duct. The common hepatic duct merges with the cystic 
duct to form the common bile duct. The common bile duct 
empties into the intestine at the sphincter of Oddi. The 
cystic duct is the duct that connects the gallbladder to the 
rest of the biliary system. Bile secreted from the liver is 
normally stored in the gallbladder until the animal eats, at 
which time contractions of the gallbladder force bile into 
the duodenum. The gallbladder concentrates and absorbs some 
biliary constituents, effectively changing bile composition 
during storage (Guyton, 1981). 
The body has a very effective system of conserving bile 
acids and maintaining a body bile acid pool. This system is 
termed enterohepatic circulation. According to Guyton 
(1981), bile acids are reabsorbed in the ileum of the small 
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intestine with about 94% efficiency. Some research, however, 
suggests that the proximal bowel, i.e., the duodenum and 
jejunum, also may play a major role in the process of bile 
acid reabsorption, especially in the pig (Juste et al., 
1988). The liver is able to remove conjugated bile acids 
better than free bile acids during enterohepatic circulation, 
although those returning to the liver from the intestine via 
enterohepatic circulation are a mixture of both conjugated 
and unconjugated forms (Coleman, 1987). It is thought that 
biliary phospholipids also may undergo enterohepatic 
circulation (Boucrot, 1972). With such a tremendous 
conservation of bile acids in the body, it is logical to 
assume that excessive excretion of bile acids via the feces 
may alter biliary and cholesterol metabolism. 
Bile flow, and therefore bile acid output, can be 
affected by many factors. Hepatic bile flow can be separated 
into two mechanisms—bile acid-dependent bile flow and bile 
acid-independent bile flow. Bile acid-dependent flow 
increases linearly with increased outputs of bile acids 
(Forker, 1977; Erlinger, 1981). Loria et al. (1989) theorize 
that the bile acids in bile induce flow and inorganic ion 
movement because of an osmotic gradient created by ionized 
bile salts present in the lumen of the bile canaliculi. 
Biliary bile acids exert similar effects on biliary 
cholesterol and phospholipids as well (Swell et al., 1968; 
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Heath et al., 1970) although this effect may be caused simply 
by increased bile flow and therefore increased volume 
secreted. Bile acid-independent bile flow enters the bile 
independently of bile acids and is induced strongly by the 
intestinal hormone secretin (Hardison and Norman, 1967; 
Forker, 1977). Evidently, secretin induces both hepatocytes 
and ductular cells to secrete bile into the biliary tubular 
system (Soloway et al., 1972). 
Bile has varied functions in the body. One of the 
primary functions is the detergent action of the bile acids 
in solubilizing dietary fats and products of fat hydrolysis. 
This solubilization facilitates the absorption of dietary 
fat, cholesterol, and fat-soluble vitamins by the intestinal 
cell. Secondly, bile acids are required for activation of 
some of the pancreatic lipolytic enzymes, such as pancreatic 
lipase-colipase. Thirdly, bile stimulates the secretion of 
water and electrolytes into the intestinal lumen from the 
intestinal surface. In addition, bile alters the motility of 
the intestine and secretion of intestinal polypeptide 
hormones (Goswami and Dupont, 1982). Bile also has an 
excretory function. As mentioned, bile is the primary route 
of cholesterol excretion from the body, either by biliary 
cholesterol and cholesterol conversion products or by bile 
acid loss in the feces. Bile also is the excretory route for 
bilirubin, a by-product of heme degradation, from the body. 
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Many commonly used drugs also are metabolized by the liver 
and subsequently excreted through the bile. In addition, 
several drugs can influence bile flow and composition, such 
as spironolactone, theophylline, and chlorpromazine 
(Okalicsanyi et al., 1986). 
Diet and bile 
Dietary factors can affect bile flow and composition. 
Factors of primary interest are dietary fats, proteins, 
fiber, and cholesterol. Balasubramaniam et al. (1985) found 
that rats fed fish oil (high in n-3 fatty acids) had an 
increased basal secretion rate of cholesterol into bile when 
compared with rats fed safflower oil (high in n-6 fatty 
acids). Safflower oil diets caused greater secretion rates 
than did coconut oil diets (high in saturated fatty acids). 
Bile acid secretion was similar for all rats. In contrast, 
other researchers have found that polyunsaturated fats fed to 
rats increased excretion of both cholesterol and bile acids 
into bile (Byers and Friedman, 1958; Ramesha et al., 1980). 
This mechanism may be the cause of the hypocholesterolemia 
noted after feeding diets high in polyunsaturated fats. 
The effects of dietary protein on bile metabolism has 
been studied extensively in relation to gallstone formation. 
Jaskiewicz et al. (1987) found no difference in bile 
composition of vervet monkeys fed either casein or soy 
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protein as the principal dietary protein source. In 
addition, both groups developed gallstones at the same rate. 
Bosaeus and coworkers (1988) found similar results in bile 
composition of humans with ileostomies fed diets containing 
either soy- or meat-protein based diets. In contrast, Beynen 
and others (1985) found that casein-fed rabbits had 
significantly increased biliary cholesterol when compared 
with soy protein-fed rabbits. Bile phospholipids and bile 
acids concentrations were not different between the two 
treatments. In addition, casein-fed rabbits had lesser 
bacterial transformation of primary bile acids to secondary 
bile acids, which possibly alters enterohepatic circulation 
(Pacini et al., 1989). Low protein diets also may affect 
significantly bile metabolism when compared with a diet that 
meets the animal's protein requirement. Rats fed a low 
protein diet (8% crude protein) had lower bile flow, lower 
bile acid secretion and bile acid-dependent bile flow, higher 
bile acid-independent bile flow, and higher biliary 
phospholipid and biliary cholesterol secretion than did rats 
fed normal protein diets (26% crude protein) (Villalon et 
al., 1987). 
Recently, the effects of dietary fiber on cholesterol 
metabolism have been studied intensely. One of the ways 
fiber mediates its effects may be through changes in 
enterohepatic circulation of bile acids. Generally, 
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researchers have shown that fiber binds bile acids and 
thereby increases the excretion of bile acids and neutral 
sterols in the feces (Vahouny et al., 1980; Ebihara and 
Schneeman, 1989; Payne et al., 1989). Evidently, different 
fiber sources bind bile acids with different affinities. For 
example, diets containing beans, which are high in soluble 
fiber similar to oat bran, increase biliary cholesterol 
output when compared with diets containing cellulose, which 
is high in insoluble fiber (Rigotti et al., 1989). 
There are species differences in the response of bile 
metabolism to dietary cholesterol. Man, rhesus monkey, 
squirrel monkey, and baboon are not able to increase bile 
acid production in response to excess dietary cholesterol but 
do increase excretion of neutral sterols, i.e., cholesterol, 
in bile and subsequently into feces. These species also 
suppress endogenous cholesterol synthesis, although the 
ability to do this varies between individuals. Dogs and 
rats, however, can increase bile acid formation and excretion 
and decrease cholesterol synthesis in response to dietary 
cholesterol to maintain cholesterol homeostasis within the 
body. These responses may occur because of differential 
changes in hepatic enzyme activity for bile acid synthesis 
(Danielsson and Sjovall, 1975). 
To conclude this section on bile metabolism, several 
drugs used to treat hypercholesterolemia that alter bile 
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metabolism and enterohepatic circulation of biliary 
components must be mentioned. These drugs include 
cholestyramine and colestipol. These drugs are called bile 
acid sequestrants and can have important effects on hepatic 
lipoprotein metabolism, decreasing plasma cholesterol 13-40% 
(Packard and Shepherd, 1982; LaRosa, 1989; Shepherd, 1989). 
Pigs as Models for Humans 
The pig has become an important and widely used model 
for research into human metabolism and disease. Popularity 
of the pig has expanded because pigs are physiologically and 
anatomically similar to humans, are readily available and 
relatively inexpensive to purchase and maintain, can consume 
and digest diets similarly to humans, and develop some of the 
same disease conditions that humans develop (Phillips and 
Tumbleson, 1986). In addition, there are several breeds and 
strains of pigs, e.g., some that are hypercholesterolemic, 
that have been developed to meet various distinct needs of 
researchers. 
Pigs can be used as models to research many different 
human diseases or conditions, including neonatal metabolism 
(Book and Bustad, 1974), immunological disease (Milliken et 
al., 1973), cancer (Oxenhandler et al., 1979), diabetes 
(Phillips et al., 1980), and severe thermal injury (Wachtel 
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et al., 1978). The pig's success as an animal model for 
humans is dependent on the fact that they are similar to 
humans with respect to the cardiovascular system, digestive 
tract, skin, nutritional requirements, bone development, and 
mineral metabolism. Because of the pig's size, multiple 
samples can be collected and surgical modifications can be 
performed with relative ease (Dodds, 1982). Several reviews 
are available on the use of swine as models (Dodds, 1982; 
Hughes, 1986; Tumbleson, 1986; Miller and Ullrey, 1987). 
One of the most extensive uses of swine as models for 
humans is research on atherosclerosis and cardiovascular 
disease. Pigs have lipoprotein patterns similar to human 
patterns (Swinkels and Demacker, 1988) and can develop 
spontaneous atherosclerosis, as evidenced by plaques that 
were found coincidentally in otherwise healthy animals (Skold 
and Getty, 1961). The atherosclerotic plaques found in swine 
have characteristics similar to human atherosclerotic 
lesions, for example, elevations and roughening of the 
intimai lining of affected vessels associated with lipid 
deposition (Reitman et al., 1982). Reitman et al. (1982) 
also demonstrated that swine respond to high fat, high 
cholesterol diets by hypercholesterolemia and increased 
incidence of atherosclerosis, as other researchers have shown 
(Greer et al., 1966; Cevallos et al., 1979). Swine have been 
used to study many aspects of lipoprotein, cholesterol, and 
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bile metabolism in humans. These research trials have 
included studies on the effects of modified lipoproteins 
(Baver et al., 1986), receptor function and catabolism of 
lipoproteins (Checovich et al., 1988), and reverse 
cholesterol transport and regression of lesions (Kim et al., 
1988). Swine are also good models for studies of bile 
synthesis and degradation and have been used in the study of 
treatment and diagnosis of cholelithiasis (Griffith et al., 
1989) and effects of diet on changes in bile constituents 
(Juste et al., 1983; Galloway et al., 1990). 
There are, however, some problems with the use of the 
pig model. Humans synthesize and secrete more VLDL than do 
pigs (Patel et al., 1975). In addition, plasma of swine does 
not contain cholesteryl ester transfer protein in as high a 
concentration as human plasma does (Ha and Barter, 1982). 
Swinkels and Demacker (1988) concluded that, although pig 
lipoprotein patterns and metabolism do not exactly duplicate 
that of a human, they are a suitable animal model for the 
study of LDL heterogeneity. 
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SECTION I. SIMPLE ENZYMATIC ASSAY FOR DETERMINING 
CHOLESTEROL CONCENTRATION IN BILE 
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ABSTRACT 
Bilirubin oxidase (EC 1.3.3.5) was used to remove 
interference by bilirubin in the assay of concentration of 
cholesterol in bile by standard enzymatic methods. Samples 
were treated for 10 minutes with nonlimiting amounts of 
bilirubin oxidase to form biliverdin from bilirubin before 
addition of cholesterol reagent. The relatively small amount 
of interference caused by biliverdin was eliminated easily by 
use of sample blanks. The method was simple, convenient, and 
not hampered by "chromogen oxidase" activity (the inherent 
ability of bilirubin oxidase to oxidize some chromogens) that 
plagues other assays of this type. By using this assay, the 
concentration of cholesterol in bile can be determined 
accurately and precisely. The elimination of bilirubin also 
would be useful in the assays of other biliary constituents 
or constituents of urine or icteric plasma. 
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INTRODUCTION 
Bile salts, phospholipid (primarily phosphatidyl­
choline) , cholesterol, and proteins are the major organic 
solutes of bile (Coleman, 1987). Bilirubin is also present, 
giving bile its characteristic color; unfortunately, this 
color interferes with several spectrophotometric assays used 
to quantify bile constituents. In addition to color 
interference, bilirubin can serve as a competitor in the 
peroxidase reaction by reacting with hydrogen peroxide. As a 
result, the chromagens are not formed completely and errors 
occur in the assay. Although the primary method of disposal 
of cholesterol from the body is through conversion to bile 
acids, cholesterol in bile also represents an excretory route 
for excess cholesterol in the body via the feces (Sabine, 
1977). The concentration of cholesterol in bile is an 
important determinant of the fraction of cholesterol 
dissolved in bile. 
The tendency of either growth or dissolution of 
cholesterol gallstones depends largely on the amount of 
dissolved cholesterol in bile. As the concentration of 
cholesterol in bile increases, formation of cholesterol 
gallstones is more likely if the concentration of other bile 
components remain unchanged (Carey and Small, 1978). Biliary 
cholesterol also has been implicated in a protective 
mechanism for the gall bladder, preventing damage induced by 
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bile salts to the mucosal lining of the gall bladder, the 
common, hepatic, and cystic bile ducts, and the small 
intestine (Jacyna et al., 1986). 
The analytical methods currently used for determining 
concentrations of cholesterol in bile are gas-liquid 
chromatographic procedures (Bailey and Brooks, 1987), which 
are laborious and time consuming. Bleaching with ultraviolet 
light for 24 hours also is used commonly to remove bilirubin 
from bile or other compounds. This method is time consuming 
and includes the risks of sample contamination, evaporation, 
or spillage. The enzymatic assay reported herein is similar 
to one reported by Fromm et al. (1980) for the determination 
of concentration of biliary cholesterol but is more 
convenient and time saving. The interference of bilirubin in 
peroxidase-coupled enzymatic procedures involving measurement 
of hydrogen peroxide spectrophotometrically is common (Witte 
et al., 1978; Click et al., 1985) and can cause erroneous 
results. This procedure eliminates interference from 
bilirubin and is potentially applicable to other analyses, 
such as quantifying other compounds in bile, urine, and 
icteric plasma, in addition to biliary cholesterol. 
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MATERIALS AND METHODS 
Samples. Hepatic bile was obtained from pigs that had 
been implanted with common bile duct and duodenal catheters. 
Samples were frozen at -20°C in screw-top vials for storage 
and then thawed at room temperature just before use. 
Chemicals and enzvmes. All reagents used were 
analytical grade. Bilirubin oxidase (from Mvrothecium 
species; EC 1.3.3.5), sodium lauryl sulfate, L-ascorbic acid, 
Diagnostic Kit 352 for total serum cholesterol, cholesterol 
standard (Accutrol calibrator A2034), and cholesterol 
calibrators (C0534) were obtained from Sigma Chemical Co., 
St. Louis, MO. 
Apparatus. A Model 2600 spectrophotometer (Gilford 
Instrument Laboratory, Inc., Oberlin, OH) was used for all 
spectrophotometric analyses. 
Reagent preparation. Bilirubin oxidase was diluted in 
distilled, deionized water to give a final concentration of 
223 U/mL. The diluted enzyme was stable at least 10 hour in 
an ice bath. The reaction buffer used for the assay 
procedure was 100 mmol/L phosphate buffer (monopotassium 
phosphate and disodium phosphate, pH 7.0) containing 10 mmol 
of sodium lauryl sulfate per liter. When stored at 4®C, this 
buffer was stable for at least two weeks. 
The cholesterol reagent was prepared according to 
manufacturer's directions by adding distilled, deionized 
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water. To obtain blank values, ascorbic acid was added to 
duplicate samples to inhibit cholesterol oxidase in the 
reagent mix. The ascorbic acid was dissolved in 0.5 M NaCl, 
and the solution was adjusted to pH 7.0. A standard curve 
was prepared with Sigma cholesterol calibrators. Adding 
bilirubin oxidase to these standards produced no deleterious 
effects; the standard curves were similar to those obtained 
when bilirubin oxidase was not added. The concentration of 
biliary cholesterol in porcine bile was assayed 20 minutes 
after pretreatment with bilirubin oxidase. 
Procedure. Pipet 30 fih of bile or 10 /nL of standard 
into four 12 X 75 mm test tubes. Add 20 /xL of reaction 
buffer and 30 juL of bilirubin oxidase solution (final amount 
7 U/tube) to all tubes. Vortex-mix briefly and incubate at 
37°C for 10 minutes. After incubating, add 50 /xL of the 
ascorbate solution to two of the tubes (these will be the 
blanks). Then, add 1 mL of cholesterol reagent to all tubes 
vortex-mix, and incubate 10 minutes at 37°C. Determine the 
absorbance of the mixture at 505 nm versus water as a blank. 
Determine the net absorbance values of the sample (subtract 
the blank absorbance values from the sample absorbance 
values) and read the concentration of cholesterol from the 
standard curve. 
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RESULTS AND DISCUSSION 
This use of bilirubin oxidase to pretreat samples for 
biliary cholesterol assay is an application of a method of 
Allain et al. (1974), with modifications by Sigma 
Diagnostics, and with use of the Sigma Diagnostics 
Cholesterol reagent after removal of interference from 
bilirubin. The cholesterol assay reagent is based on 
cholesterol esterase, cholesterol oxidase, and peroxidase 
(Allain et al., 1974). The chromophores 4-aminoantipyrine 
and p-hydroxybenzenesulfonate in the presence of hydrogen 
peroxide and peroxidase yield a quinoneimine dye, with an 
absorbance maximum at 505 nm. The intensity of the color 
produced is directly proportional to the total concentration 
of cholesterol in the sample. 
Bilirubin has a peak absorbance at 440 nm and absorbs 
some at 505 nm. This interferes with the assay to such an 
extent that use of blank samples is insufficient not only 
because of color but because bilirubin interferes 
competitively in peroxidase-coupled reactions. Bilirubin 
oxidase was used to remove this interference by facilitating 
the conversion of bilirubin to biliverdin, a compound that 
absorbs at a maximum of 320 nm and does not interfere at 505 
nm to the extent that bilirubin does. Figure 1 illustrates 
the spectra showing the removal of bilirubin from hepatic 
porcine bile treated with bilirubin oxidase. The sample's 
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Figure 1. Spectra showing the removal of bilirubin from porcine hepatic bile 
samples treated with bilirubin oxidase (A) versus those not treated (B) 
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absorbance in the 505-nm range is decreased substantially and 
is corrected readily with a sample blank. 
Bilirubin oxidase has been used to quantify bilirubin 
directly (Perry et al., 1986; Mullon and Langer, 1987) and to 
remove interference caused by bilirubin when measuring 
creatinine in serum and urine (Artiss et al., 1984). Artiss 
et al. (1984) noted that pretreatment with bilirubin oxidase 
resulted in somewhat lower concentrations of creatinine than 
did the common methods of measurement because common methods 
are affected by bilirubin interference. Therefore, results 
obtained by using pretreatment with bilirubin oxidase in 
spectrophotometric assays may be more accurate. Bilirubin 
oxidase pretreatment, however, has not been used in assays 
that measure concentrations of biliary constituents in bile; 
thus, the present procedure is unique. 
Table 1 shows data for the linear regression analysis of 
a standard curve from cholesterol calibrators (four standards 
in duplicate) and similar curves developed from cholesterol 
calibrator plus 10 and 20 fil» of porcine bile. Curves from 
calibrator plus bile are parallel to the standard curve from 
0 to 4 g/L and are linear over the same range of cholesterol 
concentrations. Regression coefficients (r) and coefficients 
of variation (CV) for the curves also are shown in Table 1. 
Regression coefficients in the range of 0.998 substantiate 
linearity, and slopes of 0.015 to 0.016 indicate that the 
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Table 1. Linear regression analyses of the standard curve 
and standards plus bile for samples pretreated with 
bilirubin oxidase 
Sample^ Slope 
10-5 
(A505 per 
mg/dL) 
y-Intercept 
(A505) 
rb CV,%° 
Std 15+0.5^ 0.007+0.010 0.998 4.93 
10 16+0.3 0.10 +0.008 0.999 2.70 
20 15+0.6 0.18 +0.013 0.997 3.83 
Std=standard curve (four standards ranging in 
cholesterol concentration from 0 to 4 g/L); 10=standards plus 
10 nL of added bile; 20=standards plus 20 fiL of added bile; 
n=3 each. 
r=correlation coefficient. 
°CV=coefficient of variation. 
"Values are mean + standard error of the mean. 
lines are parallel. Thus, the assay has good repeatability. 
The assay was linear through sample sizes ranging from 0 to 
40 fiL of bile (concentration of cholesterol in bile from 0 to 
3.6 mg/dL) with a slope of 0.009 A^Q^/mg per dL cholesterol 
and a regression coefficient of 0.997. 
Assays for cholesterol concentration in bile from 66 
pigs in two different trials have been performed in our 
laboratory (Luhman et al., 1989; Galloway et al., 1989). 
Pigs were fed diets varying in type and amount of fat and in 
amount of calcium and cholecalciferol. Mean concentration of 
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biliary cholesterol was 0.47 g/L and did not vary 
significantly with diet. 
Precision of the method was determined by assaying a 
commercial cholesterol calibrator that contained 1.6 g/L of 
cholesterol (Accutrol, Sigma Chemical Co.). Twenty-one 
separate runs were performed over 7 days to determine results 
shown in Table 2. Mean value for all samples was 1.64 g/L. 
Day means ranged from 1.77 g/L to 1.53 g/L. Run means ranged 
from 1.79 g/L to 1.49 g/L. 
Table 2. Precision of assay with bile samples^ pretreated 
with bilirubin oxidase 
Study SD^ (g/L) 
Total 0.09 
within-run 0.05 
Between-run 0.07 
Within-day • 0.02 
Between-day 0.06 
days. 
b 
^Mean=1.64 g/L for 42 samples in 21 runs over 7 
SD=Standard deviation. 
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Use of bilirubin oxidase to remove interference of 
bilirubin in certain chromogen systems has been hampered by 
the inherent ability of bilirubin oxidase to oxidize the 
chromogen and, thus, destroy the ability to absorb 
spectrophotometrically. Chromogens and chromophores affected 
by bilirubin oxidase were 4-aminophenazone and 
tribromohydroxybenzoic acid (Maguire, 1985). The current 
chromophore, 4-aminoantipyrine, may be less susceptible to 
oxidation than are other color-producing compounds. The dye 
complex was stable for at least 30 minutes; thus, no further 
precautions were necessary if absorbance was determined 
within that time frame. Absorbance values were 0.2955 at 0 
minutes, 0.2958 at 15 minutes, and 0.2967 at 30 minutes. Our 
procedure eliminates the need for ferrocyanide (Spain and Wu, 
1986), 4-dimethylamino-antipyrine (Zoppi et al., 1981), or 
other compounds that have been incorporated into peroxidase-
coupled reagent mixtures to obviate the .oxidation of 
chromogen complexes that can occur with bilirubin oxidase. 
Bilirubin interferes in spectrophotometric procedures 
that quantitate several biliary constituents in bile, 
including biliary cholesterol. In this procedure, bilirubin 
oxidase removed this interference by changing bilirubin to 
biliverdin. Biliverdin absorbs maximally at a shorter 
wavelength than does bilirubin and therefore interferes less. 
In addition, pretreatment with bilirubin oxidase removes 
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interference of bilirubin with hydrogen peroxide-coupled 
reactions. The small amount of interference caused by 
biliverdin can be eliminated easily by use of sample blanks. 
This procedure is easy, convenient, and time-efficient and 
may be readily adaptable for colorometrically measuring 
concentrations of other biliary constituents. 
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SECTION II. FATTY ACID PROFILES OF BILE AND 
LIVER MEMBRANES ARE AFFECTED BY 
TYPE OF DIETARY FAT 
77 
ABSTRACT 
A study was designed to determine the effects of diets 
that mimicked the ranges of human intakes of quantity and 
quality of fats fed to pigs (as a model for humans) on the 
fatty acid profiles of biliary phospholipids and hepatocyte 
plasma membranes. Young growing pigs were fed diets 
containing either 20% or 40% of calories as primarily either 
beef tallow, soy oil, or a 50:50 (wt:wt) blend of tallow and 
soy oil in a 2 X 3 factorial design. Pigs fed diets 
containing tallow had greater percentages of palmitoleic and 
oleic acids (P<0.05) and lesser percentages of linoleic and 
linolenic acids (P<0.05) in biliary phospholipids than did 
pigs fed diets containing soy oil. Generally, pigs fed blend 
diets had intermediate percentages of these fatty acids in 
biliary phospholipid. Hepatocyte plasma membranes collected 
from pigs fed tallow-based diets had greater percentages of 
myristic, palmitoleic, and oleic acids (P<0.05) and a lesser 
percentage of stearic acid (P=0.086) than did pigs fed soy 
oil diets. Amount of dietary fat had no effect on fatty acid 
composition of biliary phospholipids or liver membranes. In 
summary, fatty acid composition of biliary phospholipid was 
affected to a greater extent by dietary fat source than was 
that of liver membranes. The largest changes in biliary 
phospholipids were in the monounsaturated and 18-carbon 
polyunsaturated fatty acids, and the greatest changes in 
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hepatocyte plasma membranes were noted in the monounsaturated 
fatty acids. Type of dietary fat alters plasma membrane 
fatty acid composition and may alter clearance of cholesterol 
from plasma and secretion of cholesterol and bile acids into 
bile. 
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INTRODUCTION 
Relatively high concentrations of low-density 
lipoprotein (LDL)-cholesterol have been implicated as a 
causative factor for atherosclerosis. Diet, especially type 
and amount of dietary fat, can influence strongly plasma LDL-
cholesterol; saturated fatty acids that are 12-26 carbons in 
length are hypercholesterolemic and monounsaturated and 
polyunsaturated fatty acids are normo- or hypocholesterolemic 
(see McNamara, 1987 for review). The exact role that dietary 
fats play on controlling plasma cholesterol concentration is 
yet to be elucidated. 
The fatty acid composition of dietary fats has been 
shown to influence plasma and cell membrane compositions and 
possibly change several physiological processes, such as 
lipoprotein metabolism and certain cell membrane receptor 
systems. The response induced by changes in dietary fatty 
acid profiles include alteration of the fatty acid profiles 
of plasma (Kritchevsky et al., 1988; Kunnert et al., 1988) 
and tissues (Morson and Clandinin, 1986; Das and Hajra, 
1989), changes in the concentration of cholesterol in plasma 
(Shepherd et al., 1980) and tissues (Baldner-Shank et al., 
1987; Diersen-Schade et al., 1986), and effects on plasma 
membrane fluidity (Gibney and Bolton-Smith, 1988). 
Alterations in fatty acid profiles and cholesterol 
concentrations of cell membranes have been shown to affect 
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cellular functions. Morson and Clandinin (1986) showed that 
the amount of membrane fatty acids derived from linolenic 
acid increased as dietary linolenic acid concentration 
increased. The membranes that had increased concentrations 
of linolenic acid had depressed activity of glucagon-
stimulated adenylate cyclase. Other protein receptors in 
plasma membranes may be affected as well. Spady and Dietschy 
(1985) reported that receptor-dependent uptake of LDL-
cholesterol was suppressed 90% in hamsters by a high intake 
of triacylglycerols containing mostly saturated fatty acids. 
Fox et al. (1987) indicated that baboons fed 25% of the diet 
as coconut oil had a significant decrease in hepatic LDL 
receptor mRNA when compared with baboons fed peanut or olive 
oil, indicating that fatty acid profiles of cells may affect 
synthesis of receptors. 
Changes in liver cell membranes also may affect 
cholesterol excretion via biliary bile acids and cholesterol. 
In addition, the fatty acid profile of biliary phospholipids 
can be changed by changes in dietary fat source (van Berge 
Henegouwen et al., 1987), possibly indicating an increased 
capacity of the bile to carry biliary cholesterol and bile 
acids. Researchers have shown that a diet high in 
polyunsaturated fatty acids increased biliary cholesterol 
excretion (Gonzales et al., 1989; Balasubramaniam et al., 
1985) and bile acid excretion (Ramesha et al., 1980). These 
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researchers, however, used rats as there animal model. Many 
researchers have noted a species difference in biliary 
metabolism of lipids (see Danielsson and Sjovall, 1975, for 
review). 
In the present study, pigs were used as a model for 
humans to study effects of type and amount of dietary fat on 
biliary phospholipid and hepatocyte plasma membrane fatty 
acid profiles. The fatty acid composition of these two 
constituents may be mediators that control cholesterol 
excretion and therefore plasma cholesterol concentration. 
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MATERIALS AND METHODS 
Thirty crossbred, castrated male pigs, approximately six 
weeks of age, were used. Pigs were assigned randomly to one 
of the six diets shown in Table 1. Pigs were housed in an 
environmentally controlled building in individual pens on 
concrete floors covered with sawdust. Water was supplied ad 
libitum from automatic nipple waterers. Pigs were weighed 
weekly, and feed intake was adjusted to 4% of body weight on 
a dry-matter basis. 
Diets (Table 1) were fed in a completely randomized, 2 X 
3 factorial design with two amounts and three types of fat. 
Amounts of dietary fat were either 20 or 40% of calories as 
fat; types of dietary fat were tallow, soy oil, or a 50:50 
(wtiwt) blend of tallow and soy oil. Ground beef and soy 
protein isolate were used as protein sources to mimic a 
typical American diet. Crystalline cholesterol was added to 
diets as needed to equalize cholesterol intakes. Cholesterol 
was dissolved in the dietary fat source and then mixed with 
other dietary components. Pigs were fed two times daily for 
six weeks. Gross energy of the diets was verified by bomb 
calorimetry (Par Oxygen Bomb Calorimeter, Model 1241, Parr 
Instrument Co., Inc., Moline, IL). The high fat diets 
contained 3,900 kilocalories, and the low fat diets contained 
3,500 kilocalories of metabolizable energy per kilogram of 
Table 1. Ingredient composition of diets^ 
Diet 
Ingredient 20% T 20% SO 20% B 40% T 40% SO 40% B 
or ciry mauueiT" 
Ground shelled com 75.9 75.3 75.4 57.2 56.6 56.8 
Soy protein isolate^ 9.5 9.3 9.5 13.1 12.6 12.8 
Ground beef^ 4.6 4.5 4.6 6.4 6.1 6.2 
Soy oil^ - 10.3 5.0 - 24.1 11.7 
Tallow® 9.4 — 5.0 22.7 - 11.7 
Vitamins and minerals 0.6 0.6 0.6 0.6 , 0.6 0.6 
Crystalline cholesterol^ 14.6 23.3 18.7 — 20.7 10.0 
(mg/100 g feed) 
^Abbr. : 20% and 40% refer to amount of calories as fat based on metabolizable 
energy from fat, T = Tallow, SO = Soy oil, B = Blend of tallow and soy oil. 
^Supro 620, Ralston Purina Co., St. Louis, MO. 
"^Carriage House Meat and Provision Co., Ames, lA. 
d Central Soya Co., Inc., Fort Wayne, IN, donated through the courtesy of D. 
Strayer. 
®Iowa State University Meat Laboratory, Ames, lA. 
^Feed Specialties Co., Des Moines, lA, donated through the courtesy of L.• 
Russell. Guaranteed analysis (per kg.): 150 mg retinyl palmitate, 1.24 mg 
cholecalciferol, 900 mg dl-alpha-tocopheryl acetate, 136 mg menadione (synthetic 
vitamin K), 225 mg riboflavin, 1,360 mg niacin, 900 mg d-pantothenic acid, 23,700 
mg choline chloride, 1.1 mg cobalamin, and 40 mg folic acid. Hieral sources were 
calcium carbonate, sodium selenite, manganese sulfate, iron sulfate, calcium 
iodate, copper oxide, zinc oxide, magnesium oxide, and iron oxide. This premix 
was added at a rate of 50 g/10 kg feed, as-fed basis. 
^Sigma Chemical Co., St. Louis, MO. 
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feed. Protein content of diets was determined by the Kjeldahl 
method. On a dry-matter basis, low fat diets contained 15.9% 
crude protein and high fat diets contained 17.6% crude 
protein. A vitamin and mineral premix was added to the diets 
to meet or exceed daily requirements for growing pigs (NRG, 
1979). Fatty acid composition of the diets was determined by 
gas-liquid chromatography-mass spectrometry (Hewlett-Packard 
5890/5790a, Avondale, PA) (Lepage and Roy, 1986) and is shown 
in Table 2. 
During week 4, each pig was fitted with a bile duct 
catheter and duodenal catheter. Five percent halothane mixed 
with oxygen and administered by inhalation was used to induce 
anesthesia. Anesthesia was then maintained by inhalation of a 
2-4% mixture of halothane and oxygen. A mid-line incision was 
made from the xiphoid process to the umbilicus. The cystic, 
hepatic, and common bile ducts were isolated. The cystic duct 
was ligated between the gall bladder and the junction with the 
hepatic duct; the gall bladder was drained by using a needle 
and syringe. A single strand of silk suture was placed under 
the anterior end of the common bile duct. The posterior end 
of the common bile duct was ligated, and suture ends were left 
long. A small incision was made in the common bile duct 
equidistant from the two sutures for catheter placement. The 
silastic catheter (0.092 cm id, 0.125 cm od) was inserted 
through the incision until the tip was into the hepatic duct. 
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Table 2. Fatty acid composition of the diets 
Diet" 
Fatty acids'* Tallow Soy oil Blend 
wt % 
Saturated 
14:0 3.5 0.9 2.7 
16:0 33.5 21.6 28.5 
18:0 13.7 7.3 10.7 
Total 50.7 29.8 41.9 
Monounsaturated 
16:1 4.3 0.6 2.8 
18:1 26.6 19.7 22.7 
Total 30.9 20.3 25.5 
Polyunsaturated 
18:2 14.0 35.1 23.6 
18.3 4.3 14.5 8.9 
20:4 <0.1 <0.1 <0.1 
Total 18.3 49.6 32.5 
^Fatty acid composition data of 20% and 40% diets are 
nearly the same and are not reported separately. 
^Fatty acids present at less than 0.1% (except 20:4) 
were not reported. 
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The catheter was tied into place with the suture previously 
placed around the duct. The catheter also was tied to the 
distal end of the duct for stabilization. Bile was allowed to 
flow from this catheter until the abdominal incision was 
closed. 
The catheter was placed into the duodenum as described 
by Davis et al. (1985) with modification. The catheter was 
placed opposite the sphincter of Oddi and inserted 
approximately 5 cm distally. Both the bile duct and duodenal 
catheters were exteriorized through the right body wall just 
ventral to the ribs. The ends of the catheters were connected 
with a plastic Y-shaped connector in which one arm of the Y 
was capped with an injection cap. Physiological saline (0.7% 
NaCl solution, pH=7.4) was used to flush the peritoneal cavity 
before closure of the incision. Prophylactic antibiotic 
tablets (tetracycline hydrochloride) were placed in the 
abdominal cavity, and liquid antibiotic (penicillin-
dihydrostreptomycin) was injected intramuscularly at surgery 
and for two days post-surgically. The incision was closed in 
layers. The pig was bandaged with canvas pockets used to 
protect the catheters. Bile flow was checked daily during 
recovery. 
Bile samples (10 mL) were collected in week 6 of the 
dietary treatments. Bile was stored at -20°C until analyzed. 
Pigs were killed 24 hours after the initial bile collection by 
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injection of 10 mL of a 5% solution of thiamylal sodium 
intravenously (Parke-Davis, Morris Plains, NJ) to induce 
anesthesia, followed by exsanguination. Whole liver was 
collected and stored at -20°C until analyzed. 
Hepatocyte membranes (including microsomal) were 
isolated by the procedure of Hollenberger and Cuatrecasas 
(1976). Fatty acid concentration in liver membranes and bile 
was determined by gas-liquid chromatography-mass spectrometry 
by using a cyanopropylphenylmethyl silicone column (RSL-500 15 
m X 0.53 mm, Alltech Associates, Deerfield, IL) by the 
procedure of Lepage and Roy (1986). Fatty acids were 
identified by comparison to fatty acid standards (Sigma 
Chemical Co., St. Louis, MO). 
The analysis of variance was conducted using the general 
linear model (GLM) procedure of SAS (1982) was used to test 
the main effect of type and amount of dietary fat and the 
interaction between them. Orthogonal contrasts were used to 
compare means of dietary treatments. 
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RESULTS AND DISCUSSION 
Effects of dietary treatment on fatty acid profiles of 
bile and hepatic plasma membranes of pigs were studied. The 
effects of dietary treatment on plasma fatty acid composition 
of these same pigs were reported already by Faidley et al. 
(1990). Briefly, their results showed that tallow feeding 
increased the percentages of myristic, palmitic, palmitoleic, 
and oleic acids in plasma. Soy oil feeding increased the 
percentages of linoleic and linolenic acids in plasma. 
Concentrations of various fatty acids in plasma of pigs fed 
blend diets (50:50 mix of soy oil and beef tallow, wt:wt) were 
intermediate between the values obtained from pigs fed tallow 
and soy oil diets, with the exception of stearic and 
arachidonic acids. 
The diets fed to the pigs did influence the fatty acid 
composition of biliary phospholipids (Table 3). Percentages 
of myristic, palmitic, stearic, and arachidonic acids were not 
altered by dietary treatment, but, numerically, the percentage 
of palmitic acid was increased and the percentage of 
arachidonic acid was decreased in pigs fed diets containing 
beef tallow. Pigs fed diets enriched with beef tallow had a 
significantly greater percentage (P<0.05) of oleic acid in 
biliary phospholipids than did pigs fed diets containing soy 
oil or a 50:50 blend (wt;wt) of tallow and soy oil. 
Percentage of palmitoleic acid was increased (P<0.001) in pigs 
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Table 3. Effects of type of dietary fat on.fatty acid 
composition of bile phospholipids 
Type of fat^ 
Fatty acid T^ B SO SEM* 
wt % 
Myristic C
M O 0 . 0  0 . 1  0 . 1  
Palmitic 4 5 . 9  4 6 . 8  3 9 . 0  5 . 0  
Palmitoleic 4 . 9 *  3 . 3 ® ' b  2 . 6 ®  0 . 5  
Stearic 5 . 0  7 . 4  1 0 . 7  3 . 0  
Oleic 2 6 . 8 ®  1 4 . 4 ^  1 1 . 7 b  2 . 0  
Linoleic 1 3 . 4 ®  2 2 . 5 b  2 9 . 5 b  3 . 0  
Linolenic 0 . 1 ®  
0
 
H
 l. o b  0 . 2  
Arachidonic 3 . 8  4 . 6  5 . 3  1 . 0  
Total^ 2 8 3 . 0  2 8 2 . 4  2 5 0 . 5  5 1 . 0  
^ Means having different superscripts in the same row 
differ (P<0.05). 
^ Abbr.: see Table 1. 
3 Values for each fat type are the means of pigs fed 20% 
and 40% of calories as fat. 
^ SEM = Pooled standard error of the mean. 
^ Expressed as ng/100 ml bile. 
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fed diets containing tallow when compared with pigs fed soy 
oil diets; percentage of palmitoleic acid in bile 
phospholipids in pigs fed blend diets was intermediate between 
the other two diets. Pigs fed diets enriched with soy oil or 
the blend of fats had significantly greater percentages of 
linoleic and linolenic acids in bile than did pigs fed tallow-
containing diets (P<0.05). Type of fat did not affect the 
total concentration of biliary phospholipids. 
Palmitic, oleic, and linoleic acids were the predominant 
fatty acids in the biliary lipids of pigs in this experiment 
and accounted for 80.2 to 86.1% of the total fatty acids in 
bile, van Berge Henegouwen et al. (1987) found that palmitic, 
oleic, and linoleic acids accounted for approximately 86% of 
the total fatty acids in bile of humans. Similar results were 
reported by Ahlberg et al. (1981). However, Balasubramaniam 
et al. (1985) noted that, in general, the fatty acid 
composition of phospholipids in the bile reflected the fatty 
acid composition of different diets that were enriched with 
coconut, safflower, or fish oils. In our study, it seemed 
that linoleic acid replaced both palmitic and oleic acids 
without preference but not to the extent that was present in 
the diet. 
Previous work has shown that diets rich in 
polyunsaturated fatty acids increased cholesterol secretion 
into bile (Balasubramaniam et al., 1985; Ramesha et al., 
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1980), suggesting that polyunsaturated fatty acid 
incorporation into bile phospholipids increases the transfer 
of cholesterol into bile. If so, the changes noted in biliary 
fatty acid composition may influence changes in concentration 
of plasma cholesterol, indicating a possible mechanism for the 
hypocholesterolemic effects of polyunsaturated fatty acids. 
It is unknown at this time if a similar hypothesis can be 
suggested for the effects of monounsaturated fatty acids on 
biliary cholesterol secretion. 
Amount of fat in the diet had no effect on percentages 
of fatty acids in biliary phospholipids (Table 4). Although 
numerically different, concentration of total biliary fatty 
acids were not different (P=0.32) between the diets containing 
different types of fats. 
Table 5 shows the effects of type of dietary fat on 
fatty acid composition of hepatocyte plasma membranes. Pigs 
fed diets containing beef tallow had increased percentages of 
myristic, palmitoleic, and oleic acids in liver cell membranes 
when compared with those of pigs fed diets high in soy oil 
(P<0.05) or in pigs fed a 50:50 blend of the two fats. 
Percentages of myristic and oleic acids were intermediate for 
pigs fed the blend diet when compared with those fed diets 
high in the two primary fat types (P<0.05). Tallow is 
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Table 4. Effects of amount of dietary fat on fatty acid 
composition of biliary phospholipids 
Amount of fat® 
Fatty acid 20%^ 40% SEM° 
Wt % 
Myristic 0.1 0.1 0.1 
Palmitic 46.8 41.0 4.0 
Palmitoleic 3.8 3.4 0.4 
Stearic 6.8 8.7 2.0 
Oleic 16.5 18.8 2.0 
Linoleic 20.4 23.3 2.0 
Linolenic 0.6 0.7 0.2 
Arachidonic 5.1 4.0 1.0 
Total^ 242.6 301.3 41.7 
® Abbr.; see Table 1. 
^ Values for each amount of fat are the means from pigs 
fed T, B, and SO diets. 
° SEM = Pooled standard error of the mean. 
^ Expressed in ng/100 ml bile. 
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Table 5. Effects of type of dietary fat on fatty acid 
composition of hepatocyte membranes 
Type of fat^ 
Fatty acid T^ B SO SEM* 
wt % 
Myristic 0 . 3 *  0 . 2 ^  0
 
H
 0
 
0 . 0 3  
Palmitic 2 8 . 1  2 7 . 5  2 6 . 1  0 . 9  
Palmitoleic 1 . 4 *  0 . 9 b  0 . 5 b  0 . 1  
Stearic^ 3 7 . 3 *  3 9 . 0 * ' ^  4 3 . 8 ^  2 . 0  
Oleic 1 5 . 3 *  H
 
to
 
to
 tr
 
9 . 5 =  0 . 7  
Linoleic 9 . 3  1 1 . 6  1 2 . 2  1 . 3  
Linolenic 2 . 7  3 . 4  3 . 2  0 . 6  
Arachidonic 5 . 7  5 . 3  4 . 7  0 . 5  
^ Means having different superscripts in the same row 
differ (P<0.05), except that for stearic acid. 
2 Abbr.: see Table 1. 
3 Values for each fat type are the means of pigs fed 20% 
and 40% of calories as fat. 
^ SEM = Pooled standard error of the mean. 
® P=0.086. 
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relatively high in concentration of myristic, palmitoleic, 
and oleic acids; so, this trend of increased concentrations 
of myristic, oleic, and palmitoleic acids would be expected. 
Percentage of stearic acid was higher (P=0.086) in the liver 
membranes of pigs fed diets containing soy oil than that in 
those of pigs fed diets containing beef tallow. The reasons 
for this is unknown because soy oil is relatively low in 
stearic acid, but the increase in stearic acid in liver cell 
membranes of pigs fed soy oil follows the trend seen in the 
percentage of stearic acid in the bile (Table 3), in which 
percentage of stearic acid in the bile was numerically higher 
(P=0.38) when feed containing soy oil was fed. 
Kritchevsky et al. (1988) reported total liver fatty 
acids of rats fed several diets differing in fatty acid 
composition and noted large changes in percentages of several 
fatty acids because of dietary treatments; these results are 
probably because of the large amount of triacylglycerol that 
would be included in the assayed samples. They found 
palmitic and oleic acids to be the major fatty acids in liver 
lipids. In contrast, palmitic and stearic acids were the 
major fatty acid components of the hepatocyte plasma 
membranes of pigs in the current study, with oleic acid being 
the third most prevalent. 
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Hamiti et al. (1988) indicated that palmitic acid was the 
primary fatty acid of liver plasma membranes (approximately 
25%) in rats fed diets differing in source of fat. 
Percentages of stearic, oleic, linoleic, and arachidonic 
acids ranged from 9.1-20.0% in pigs fed the test diets. 
Their research indicated that saturated fatty acids derived 
from butter caused increased percentages of oleic and 
palmitoleic acids and decreased percentage of linoleic acid. 
This agrees with our results for pigs fed saturated fatty 
acids as beef tallow. 
Das and Hajra (1989) found significantly higher 
percentages of stearic acid (50.6%) compared with palmitic 
acid (16.0%) in lysophosphatidic acid of rats fed a chow 
diet. Saturated fatty acids were the primary group 
(approximately 80%) of fatty acids found in the lyso form, 
indicating a differential fatty acid composition for this 
form of phospholipid. It is unknown why lysophosphatidic 
acid would differ in fatty acid profile from other 
phospholipids but the difference may indicate a preference by 
certain enzymes of phospholipid synthesis for saturated fatty 
acids. 
The most consistent change in the fatty acid profiles of 
the hepatocyte plasma membranes from the pigs in our study 
were in percentages of the monounsaturated fatty acids 
(palmitoleic and oleic acids). This agrees with research 
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done by Farnworth and Kramer (1987) and Kramer (1980). In 
the former work, the researchers noted that fatty acid 
patterns of liver phospholipids in pigs were generally 
consistent but that the percentages of monounsaturated fatty 
acids were subject to dietary manipulation and therefore were 
the exception. 
Amount of fat fed to pigs had little effect on fatty 
acid profiles of hepatocyte plasma membranes (Table 6). 
Percentage of myristic acid was increased in pigs fed 40% of 
calories as fat when compared with pigs fed 20% of calories 
as fat. No other changes were noted. 
The fatty acid compositions of biliary phospholipids and 
hepatocyte plasma membranes generally reflected dietary fatty 
acid intakes in the current study. However, it is not a true 
reflection of dietary intake because of the interaction of 
fatty acid intake and metabolism. For example, liver cell 
membranes seem to have a maximum threshold concentration of 
polyunsaturated fatty acids, which may be a protective 
mechanism of the cells to prevent excessive plasma membrane 
fluidity and therefore functional aberrations. In addition, 
the body may convert dietary fatty acids into different fatty 
acids by elongation or desaturation to meet metabolic 
demands. How these fatty acids can influence biliary 
excretion of cholesterol, concentration of plasma lipoprotein 
cholesterol, cell membrane bound low-density lipoprotein-
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Table 6. Effects of amount of dietary fat on.fatty acid 
composition of hepatocyte membranes 
Amount of fat^ 
Fatty acid 20%^ 40% SEM* 
wt % — 
Myristic 0.2* 0.3b 0.02 
Palmitic 27.0 27.4 0.8 
Palmitoleic 0.8 1.1 0.1 
Stearic 40.5 39.6 1.7 
Oleic 12.4 12.2 0.6 
Linoleic 10.7 . 11.3 1.1 
Linolenic 2.9 3.2 0.5 
Arachidonic 5.5 5.0 0.4 
^ Means having different superscripts in the same row 
differ (P<0.05). 
^ Abbr.: see Table 1. 
Values for each amount of fat are the means from pigs 
fed T, B, and SO diets. 
^ SEM = Pooled standard error of the mean. 
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receptor function and other aspects of lipid metabolism is 
being studied in-depth and offers subjects for future 
research. 
In summary, fatty acid composition of bile was 
influenced to a greater extent by type of dietary fat than 
was that of hepatocyte plasma membranes. The greatest 
changes in bile were noted in the monounsaturated and 18-
carbon polyunsaturated fatty acids. Greatest changes in 
liver membranes were noted in the percentages of myristic 
acid and in monounsaturated fatty acids. Amount of dietary 
fat had little effect on fatty acid profiles of biliary 
phospholipids and hepatocyte plasma membranes in these pigs. 
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SECTION III. POSTPRANDIAL LIPOPROTEIN COMPOSITION 
IN PIGS FED DIETS VARYING IN 
TYPE AND AMOUNT OF DIETARY FAT 
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ABSTRACT 
To determine the effects of diet on postprandial 
lipoprotein composition, 30 8-week-old castrated male pigs 
were fed one of six diets for six weeks in a 2 X 3 factorial 
design with two amounts (20% and 40% of calories) and three 
principal types of dietary fat (soy oil, tallow, and a 50:50 
blend of soy oil and tallow). At the end of week 6, a "12-
hour fasted" blood sample was drawn. Pigs then were fed, and 
blood samples were drawn 1 and 4 hours later. In low-density 
lipoproteins (LDL), concentrations of free cholesterol and 
esterified cholesterol were greater in pigs fed 40% of 
calories as fat than in pigs fed 20% of calories as fat 
(P<0.02). Pigs fasted for 12 hours had lesser concentrations 
of triacylglycerol and phospholipid in LDL than did pigs 
fasted for 1 and 4 hours (P<0.001). In high-density 
lipoprotein (HDL), esterified cholesterol and phospholipid 
concentrations were greater in pigs fed 40% of calories as 
fat than in HDL of pigs fed 20% of calories as fat (P<0.01). 
Concentration of triacylglycerol was lesser in HDL after a 
12-hour fast than 1 or 4 hour after feeding (P<0.05). A 
greater concentration of triacylglycerol was found in very 
low-density lipoprotein (VLDL) of pigs fed diets high in soy 
oil than in pigs fed diets containing tallow or a blend of 
tallow and soy oil (P<0.04) and in pigs fed 40% of calories 
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as fat than in pigs fed 20% of calories as fat (P<0.01). 
Plasma of pigs fed 40% of calories as fat had a greater 
concentration of both forms of cholesterol than did plasma of 
pigs fed 20% of calories as fat (P<0.01). Concentration of 
triacylglycerol in plasma was lesser after a 12-hour fast 
than 4 hours after feeding and was greater in pigs fed 40% of 
calories as fat than in pigs fed 20% of calories as fat 
(P<0.01). Overall, type and amount of fat differentially 
affected the composition of lipoproteins from postprandial 
and fasted pigs, with amount of dietary fat having a greater 
effect than type of dietary fat. In addition, lipoprotein 
composition changes with time after a meal but is not 
affected greatly by type of dietary fat. 
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INTRODUCTION 
Major changes occur in concentration of lipoprotein 
cholesterol and rate of triacylglycerol metabolism after a 
meal containing fat is ingested. Because humans are meal-
eaters and spend a significant proportion of the day in a 
postprandial state, it is important to gain knowledge about 
lipoprotein composition in the postprandial state in 
comparison with the fasted state. Absorption and transport 
of dietary fats from the gastrointestinal tract and into the 
blood stream can be mediated by plasma lipoproteins (Bisgair 
and Glickman, 1983). In addition, intestinally derived 
lipoproteins have been implicated in atherogenesis 
(Zilversmit, 1979). These findings further support the need 
for additional research efforts on lipoprotein concentration 
and composition of postprandial blood. 
Lipoprotein compositional changes in the postprandial 
state have been characterized by several researchers. 
Generally, early studies measured HDL, LDL, and VLDL 
composition in subjects fed only one experimental diet 
(Havel, 1957; Havel et al., 1973). Redgrave and Carlson 
(1979) further separated lipoprotein fractions into 
chylomicrons, chylomicron remnants, and large and small VLDL, 
but, like others, used only one experimental diet. These 
researchers determined that postprandial hypercholesterolemia 
was the result of chylomicron remnants rather than of intact 
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chylomicrons. This finding led to the hypothesis that 
remnant clearing was influenced by transfer of chylomicron 
components to HDL. More recently, researchers have separated 
the HDL fraction of plasma into HDLg and HDL^ to determine 
the composition and relative concentration of these 
lipoproteins after a meal (Patsch et al., 1983; Groot and 
Scheek, 1984) and to compare their formation and 
compositional changes with changes in the composition of 
triacylglycerol-rich 1ipoproteins. 
The focus of recent research has been on the changes 
reflected postprandially by the addition of newly 
synthesized, triacylglycerol-rich lipoproteins to the plasma 
and their interaction with other lipoproteins, especially the 
HDL subspecies. The relationship between these two 
lipoproteins is that HDL components may be derived from 
transfer of substances from chylomicrons or VLDL during 
lipolysis (Tall et al., 1986; Tall, 1986; Cohn et al., 1988). 
This transfer of components to HDL, and thus depletion from 
the more atherogenic chylomicrons and VLDL, may be one reason 
for the protection HDL seems to provide against 
atherosclerosis. 
Although some research has been completed on 
postprandial lipoprotein metabolism, investigation is still 
needed to determine differential effects of different types 
of dietary fats or different concentrations of dietary fat or 
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cholesterol. A recent study suggested no differences in 
humans fed either soy oil or a blend of soy oil plus cream 
from milk in a high fat meal (Cohn et al., 1988). The data 
indicated that the postprandial response in plasma 
lipoproteins is dependent on age and gender of the subject. 
The study, however, did not compare amounts of dietary fat or 
long-term feeding of a diet enriched in certain types of 
fatty acids. The emphasis of the study presented here is to 
compare three types and two amounts of dietary fat on 
postprandial lipoprotein composition in pigs after feeding 
the dietary treatments for six weeks. 
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MATERIALS AND METHODS 
Thirty crossbred, castrated male pigs, approximately six 
weeks of age, were used. Pigs were assigned randomly to one 
of the six diets shown in Table 1. Pigs were housed in an 
environmentally controlled building in individual pens on 
concrete floors covered with sawdust. Water was supplied ad 
libitum from automatic nipple waterers. Pigs were weighed 
weekly, and feed intake was adjusted to 4% of body weight on 
a dry-matter basis. 
Diets (Table 1) were fed in a completely randomized, 2 X 
3 factorial design with two amounts and three types of fat. 
Amounts of dietary fat were either 20% or 40% of calories as 
fat; types of supplementary dietary fats were tallow, soy 
oil, or a 50:50 (wt:wt) blend of tallow and soy oil. Ground 
beef and soy protein isolate were used as protein sources to 
mimic a typical American diet. Crystalline cholesterol was 
dissolved in the dietary fat source and then added to diets 
as needed to equalize cholesterol intakes. Pigs were fed two 
times daily for six weeks. Gross energy of the diets was 
verified by bomb calorimetry (Par Oxygen Bomb Calorimeter, 
Model 1241, Parr Instrument Co., Inc., Moline, IL). The high 
fat diets contained 3,900, kilocalories and the low fat diets 
contained 3,500 kilocalories of metabolizable energy per 
Table 1. Ingredient composition of diets^ 
Diet 
Ingredient 20% T 20% SO 20% B 40% T 40% SO 40% B 
% of dry matter 
Ground shelled com 75.9 75.3 75.4 57.2 56.6 56.8 
Soy protein isolate^ 9.5 9.3 9.5 13.1 12.6 12.8 
Ground beef^ 4.6 4.5 4.6 6.4 6.1 6.2 
Soy oil^ - 10.3 5.0 - 24.1 11.7 
Tallow® 9.4 — 5.0 22.7 - 11.7 
Vitamins and minerals 0.6 0.6 0.6 0.6 ^ 0.6 0.6 
Crystalline cholesterol^ 14.6 23.3 18.7 — 20.7 10.0 
(mg/100 g feed) 
^Abbr. : 20% and 40% refer to amount of calories as fat based on metéJDolizcible 
energy from fat, T = Tallow, SO = Soy oil, B = Blend of tallow and soy oil. 
^Supro 620, Ralston Purina Co., St. Louis, MO. 
^Carriage House Meat and Provision Co., Ames, lA. 
*^Central Soya Co., Inc., Fort Wayne, IN, donated through the courtesy of D. 
Strayer. 
®Iowa State University Meat Laboratory, Ames, lA. 
f Feed Specialties Co., Des Moines, lA, donated through the courtesy of L. 
Russell. Guaranteed analysis (per kg.): 150 mg retinyl palmitate, 1.24 mg 
cholecalciferol, 900 mg dl-alpha-tocopheryl acetate, 136 mg menadione (synthetic 
vitamin K), 225 mg riboflavin, 1,360 mg niacin, 900 mg d-pantothenic acid, 23,700 
mg choline chloride, 1.1 mg cobalamin, and 40 mg folic acid. Mieral sources were 
calcium carbonate, sodium selenite, manganese sulfate, iron sulfate, calcium 
iodate, copper oxide, zinc oxide, magnesium oxide, and iron oxide. This premix 
was added at a rate of 50 g/10 kg feed, as-fed basis. 
^Sigma Chemical Co., St. Louis, MO. 
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kilogram of feed dry-matter. Protein content of diets was 
determined by the Kjeldahl method. On a dry-matter basis, 
low fat diets contained 15.9% crude protein and high fat 
diets contained 17.6% crude protein. A vitamin and mineral 
premix was added to diets to meet or exceed daily 
requirements for growing pigs (NRC, 1979). 
Femoral arterial catheters were implanted into pigs 
during week 4 of the feeding period for blood collection. 
Blood (10 mL) was collected after a 12-hour fast. Pigs then 
were fed a meal of treatment diet (2% of body weight), and 
blood samples were taken 1 and 4 hours after feeding. Blood 
was collected into tubes containing disodium 
ethylenediaminetetraacetate (EDTA) used as an anticoagulant. 
Plasma was separated from blood cells by centrifugation. 
Density gradient ultracentrifugation (Beckman L8-70, Beckman 
Instruments, Inc., Palo Alto, CA) was used to separate the 
plasma into VLDL/chylomicron, LDL, and HDL fractions (Havel 
et al., 1955). One set of samples was stained with sudan 
black B before ultracentrifugation to verify separation of 
lipoproteins. Samples were stored at -20°C until analyses. 
There was insufficient volume of several of the 12-hour VLDL 
samples; consequently, concentration of cholesterol was not 
determined in these samples. 
Concentrations of free and total cholesterol in plasma 
and lipoprotein fractions were determined enzymatically by 
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the procedure of Omodeo Sale et al. (1984) with 
modifications. In addition to the standard assay procedure, 
samples were run with all reagents except cholesterol oxidase 
and cholesterol esterase in the reaction mixture to measure 
endogenous peroxides, which subsequently were corrected for. 
The absorbance of samples and sample blanks were read at 505 
nm on a Gilford model 2600 spectrophotometer (Gilford, 
Oberlin, OH). 
Triacylglycerol concentrations were determined in plasma 
and lipoprotein fractions enzymatically (Sigma Triglyceride 
(GPO-Trinder) Kit No. 339, Sigma Chemical Co., St. Louis, MO) 
by the method of NcGowan et al. (1983). Concentrations of 
phospholipids were determined enzymatically by the method of 
Takayama et al. (1977), which detects choline-containing 
phospholipids. In plasma, 95% of the phospholipids contain 
choline. The method of Bradford (1976) was used to determine 
concentrations of protein in all samples. Bovine serum 
albumin was used as the standard. 
The analysis of variance was conducted using the general 
linear model (GLM) procedure of SAS (1982) to compare effects 
of type and amount of dietary fat in plasma and lipoprotein 
components. Hourly values were analyzed also as repeated 
measures in a split-plot design. Orthogonal contrasts were 
used to compare the results of dietary treatments. Treatment 
differences reflected differences in type and amount of 
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dietary fat and there were no significant interactions; 
therefore, effects of type and amount of dietary fat are 
reported rather than treatment effects. 
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RESULTS AND DISCUSSION 
On a percentage basis, composition of VLDL/chylomicron, 
LDL, and HDL fractions collected from pigs in this study 
agree with the values reported for lipoproteins collected 
from human subjects (Mead et al., 1986). Minor discrepancies 
were noted in the percentage of total cholesterol in VLDL (a 
difference of approximately 5% in total VLDL) and in 
percentage of phospholipid in HDL (a difference of 
approximately 5% in total HDL). Percentages of all other 
components in the lipoprotein fractions where within the 
range reported. 
Effects on LDL 
Table 2 shows the composition of LDL as affected by time 
after feeding and source of dietary fat. Concentrations of 
free and total cholesterol in LDL were not affected by time 
after a meal, although concentrations in samples taken 4 
hours after feeding tended to be decreased.• Cohn et al. 
(1988) found similar results in human subjects; free 
cholesterol and cholesteryl ester concentrations in LDL were 
decreased 3 hours postprandially. At 1 hour postprandially, 
free cholesterol was increased significantly in pigs fed 
diets enriched with soy oil and total cholesterol was 
significantly increased in pigs fed diets containing a blend 
of tallow and soy oil (P<0.05). In addition, concentration 
of both free and total cholesterol were increased (P<0.05) in 
Table 2. Composition of LDL as affected by type and amount of dietary fat and time 
after feeding^ 
Type of fat^ Amount of fat^ 
Component* T B SO SEM^ 20% 40% SEM^ 
mg/dL 
Free cholesterol 
1 hour 11.7^ 16.0^'^ 17.5^ 2.1 12 .1  17.4^ 1.7 
4 hour 13.9 12.7 14.7 1.8 11.4^ 16.1* 1.4 
fasted 15.5 16.6 15.5 2.4 14.2 17.6^ 2.0 
mean 13.7 15.0 15.5 2.1 12.7* 16.8^ 1.7 
Total cholesterol 
1 hour 46.1^ 60.4 54.3a,b 5.1 47.2* 60.0^ 4.1 
4 hour 52.2 51.7 48.8 5.4 45.0 56.8 4.4 
fasted 55.0 62.9 54.2 8.4 52.4 62.3, 
mean 51.1 57.9 51.9 6.5 47.7* 59.5b 5.3 
Phospholipid 
1 hour" 
4 hour® 
fasted^ 
mean 
18.1 19.3 23.9 3.0 15.6* 25.8^ 
25.3b 
31.8* 
2.5 
20.6 19.5 23.3 3.1 16.9^ 2.5 
29.5 31.0 21.6 3.7 22.9* 3.1 
22.2 22.8 22.9 3.4 C
O H
 to
 2.8 
Triacylglycerol 
Protein 
1 hour^ 
4 hour^ 
fasted* 
mean 
11.1 11.0 15.1 2.3 11.3 13.7 1.8 
12.6 11.3 15.0 1.9 11.3 14.6 1.5 
5.5 1.1 5.2 5i7 0.9 
10.1 9.9 11.8 1.9 9.7 11.5 1.6 
1 hour^ 
4 hour^ 
fasted" 
mean 
28.3 
32.0 
2 2 . 6  
27.6 
34.6 
30.7 
2 0 . 6  
27.9 
34.7 
33.4 
16.9 
26.9 
5.1 
5.7 
4.4 
4.9 
29.0 
28.4 
19.1 
25.0 
36.0 
35.6 
21.0 
30.0 
4.1 
4.6 
3.6 
4.0 
^Table is separated into type of fat effects and amount of fat effects. Times 
are separated into length of time after the meal. 
^T=tallow, B=50:50 (wt:wt) blend of tallow and soy oil, SO=soy oil. 
^20%=20% of calories as fat, 40%=40% of calories as fat. 
^Means with the different superscript letters (a and b) in a row within type 
or amount of fat differ (P<0.05). 
®SEM=standard error of the mean. 
^Refers to time after a meal. Fasted samples were taken 12 hours after the 
previous meal. Times with different superscript letters (c and d) within a 
component of the lipoprotein are different over all fat sources (P<0.05). 
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LDL of pigs fed 40% of calories as fat when compared with 
pigs fed 20% of calories as fat. This is in agreement with 
findings reported by Siebert et al. (1987) who found plasma 
cholesterol concentration to be increased with greater fat 
intake. Source of fat had no effect on total cholesterol 
concentrations in LDL over all times. These findings are 
consistent with studies done by Howard et al. (1965) and 
Walsh et al. (1983). The reason there was no effect of type 
of fat on concentrations of total cholesterol in LDL.may be 
because the saturated fat source used was tallow, which is 
relatively high in stearic and oleic acids. These fatty 
acids may play a protective role against hypercholesterolemia 
(Bonanome and Grundy, 1988). 
Concentration of phospholipid in LDL of pigs was 
decreased 1 and 4 hours postprandially (P<0.05) when compared 
with that in 12-hour fasted samples (Table 2). This was not 
the case, however, for pigs fed soy oil. In contrast, Cohn 
et al. (1988) found no differences in LDL-phospholipid 
concentrations postprandially. In addition, higher fat diets 
caused increased concentrations of phospholipid in the LDL 
fraction of pigs. 
Concentrations of triacylglycerol and protein in LDL 
were increased 1 and 4 hours postprandially (P<0.05) when 
compared with values in samples from fasted pigs (Table 2). 
Type and amount of fat had no effect on concentrations of 
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triacylglycerol or protein in LDL in this study. 
Effects on HDL 
The concentration of free and total cholesterol in HDL 
was unaffected by type of fat or time after feeding (Table 
3). Total cholesterol in HDL was less in pigs fed 20% of 
calories as fat when compared with pigs fed 40% of calories 
as fat. Bowman et al. (1988) also found lesser HDL-
cholesterol in human subjects fed a diet that was 
significantly lower in fat content. The results from the 
present study also agree with Groot and Scheek (1984) who 
found no postprandial change in concentrations of HDL-free 
cholesterol or HDL-cholesteryl ester. 
Concentrations of HDL-phospholipid and protein were 
decreased and those of HDL-triacylglycerol was increased 
postprandially (P<0.05, Table 3). Cohn et al. (1988) noted a 
trend to decreased HDL-phospholipid postprandially in humans. 
In contrast, Groot and Scheek (1984) and Tall et al. (1982) 
found that the concentration of phospholipid in HDL was 
increased at 8 hours postprandially, but no change from 
baseline was seen at 3 or 5 hours after a meal. Tall (1986) 
suggests that 5 to 10 hours after a meal may be needed to see 
changes in HDL composition. Increased concentrations of 
phospholipid in HDL may have occurred after 4 hours 
postprandially in this study, or pigs may have not yet been 
Table 3. Composition of HDL as affected by type and amount of dietary fat and time 
after feeding^ 
Type of fat^ Amount of fat" 
Component B SO SEM" 20% 40% iSEM" 
Free cholesterol 
1 hour® 
4 hour 
fasted 
mean 
Total cholesterol 
1 hour 
4 hour 
fasted 
mean 
-mg/dL-
Phospholipid 
1 hour^ 
4 hour* 
fasted® 
mean 
3.8 
3.8 
3.3 
3.7 
23.3 
2 2 . 0  
19.5 
21.6 
21.9 
32.8 
48.3 
34.0 
3.2 
3.0 
3.7 
20.9 
21.2 
24.0 
22.4 
19.5 
35.5 
50.3 
34.5 
3.7 
3.6 
3.6 
3.6 
18.9 
19.0 
19.8 
19.6 
36.6 
20.5 
38.7 
51.7 
0 . 6  
0.5 
0 . 6  
0.6 
3.8 
2.9 
3.0 
3.3 
4.1 
6.1 
10.9 
7.7 
3.3 3.7 0.4 
3^4 lii 0^ 
3.4 3.9 0.5 
16.7 25.4 3.1 
17.5 24.0 2.4 
17.8 24.4^ 2^ 
17.6® 24.6° 2.7 
16.9 24.4 3.4 
29.7 41.3 5.0 
41.1 59.1 8.9 
28.4® 41.4b 6.3 
Triacylglycerol 
Protein 
1 hour° 
4 hour^ 
fasted* 
mean 
1 hour° 
4 hour^ 
fasted* 
mean 
5.6 5.6 5.0 1.2 5.1 5.7 0.9 
4.8 4.8 7.7 1.1 5.6 6.0 0.9 
1.4 1.6 2.2 0.5 1.5 2.0 0.4 
3.9 4.0 5.0 1.1 4.1 4.6 0.9 
46.2 53.6 54.3 6.3 49.5 53.2 5.1 
46.9 49.2 44.0 5.8 44.4 49.2 4.7 
55.4 61.0 63.8 6.2 57.5 62.6 5^ 
49.5 55.4 54.3 4.9 51.0 55.0 4.0 
^Table is separated into type of fat effects and amount of fat effects. 
Times are separated into length of time after the meal. 
^T=tallow, B=50:50 (wt:wt) blend of tallow and soy oil, SO=soy oil. 
^20%=20% of calories as fat, 40%=40% of calories as fat. 
^Means with the different superscript letters (a and b) in a row within 
type or amount of fat differ (P<0.05). 
5 SEM=standard error of the mean. 
^Refers to time after a meal. Fasted refers to samples taken 12 hours 
after the previous meal. Times with different superscript letters (c,d, and 
e) within a component of the lipoprotein are different over all fat sources 
(P<0.05). 
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at baseline concentrations of phospholipid in HDL after a 12-
hour fast. In addition, pigs fed 40% of calories as fat had 
higher concentrations of HDL-phospholipid than did pigs fed 
20% of calories as fat, which may reflect an increase in the 
number of HDL particles and follows the trend in 
concentration of total cholesterol in HDL. 
The increase in HDL-triacylglycerol concentrations 
postprandially (Table 3) are in agreement with that found by 
Cohn et al. (1988) and Groot and Scheek (1984). Type and 
amount of fat did not affect HDL-triacylglycerol 
concentrations in our study. 
The concentration of HDL-protein was decreased 
postprandially. This agrees with Groot and Scheek (1984) who 
noted a decrease in protein concentration in HDL 3 hours and 
no change 5 or 8 hours after a meal. In contrast, 
observations of Tall (1986) and Havel et al. (1973) suggest 
an increase in concentration of HDL-protein because of 
transfer of apolipoproteins to HDL particles from 
chylomicrons. Time of sampling may affect the values 
obtained in our study. The decrease in concentration of 
protein in HDL fraction also may have been caused by a 
decrease in number of HDL particles. 
Metabolism of chylomicrons in the blood postprandially 
may change significantly the composition and metabolism of 
HDL. This may be an important physiological phenomenon to 
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the body in terms of control of postprandial lipemia. 
Chylomicron particles are thought to transfer phospholipid, 
apoA-I, and A-II to HDL; HDL, in contrast, transfer 
cholesteryl ester and apoE and C to chylomicron remnants. It 
has been theorized that 5 to 10 hours after a meal may be 
required to see major alterations in HDL composition (Tall, 
1986). For these reasons. Tall (1986) suggested at least a 
14-hour fast before a meal when studying postprandial 
lipoprotein metabolism. The pigs in this study were fasted 
12 hours, which may have caused some minor discrepancies in 
1- hour samples of HDL. 
Effects on VLDL/chvlomicrons 
Very-low-density lipoproteins and chylomicrons were 
isolated jointly in the samples taken after feeding. 
Metabolism of chylomicrons produces chylomicron remnants, 
which are potentially very atherogenic particles (Zilversmit, 
1979). High-density lipoproteins may provide protection 
against atherosclerosis because metabolism of HDL can affect 
metabolism of chylomicron remnants. In this study, volume of 
some of the VLDL/chylomicron samples was insufficient and, 
consequently, concentration of cholesterol could not be 
determined in them; these are noted on Table 4. 
No statistical differences (P<0.05) in comparisons of 
concentration of free or total cholesterol in 
VLDL/chylomicrons were noted (Table 4). The samples taken 4 
Table 4. Composition of VLDL/chylomicrons as affected by type and amount of dietary 
fat and time after feeding^ 
Type of fat' Amount of fat" 
Component B SO SEM" 20% 40% SEM-
-mg/dl-
Free cholesterol 
1 hour® 0.5 0.4 1.5 0.7 
4 hour 1.3 1.2 1.9 0.5 
fasted" 0.8 1.4 0.9 0.4 
mean 0.9 0.9 1.5 0.5 
0.2 
1.1 
iiO 
0.7 
1.3 
1.9 
la 
1.5 
0.5 
0.4 
0.4 
0.4 
Total cholesterol 
1 hour 
4 hour 
fasted' 
mean 
1.7 
1.4 
2^1 
1.3 
1.1 
3.7 
2.3 
2.3 
2.5 
3.0 
1.8 
2.5 
1.0 
0.9 
0 . 6  
0.9 
0.8 
2 . 8  
1^ 
1.7 
2.5 
3.1 
2 . 0  
2 . 6  
0.8 
0 . 8  
0.5 
0.7 
Phospholipid 
1 hour 
4 hour 
fasted 
mean 
2.7 
2 . 2  
2.4 
2.4 
1.6 
2.7 
3.0 
2.5 
3.2 
2.4 
3^ 
3.0 
0 . 8  
0.9 
0.7 
0 . 8  
1.8 
2.0 
2 . 8  
2 . 2  
3.1 
3.3 
2^9 
3.1 
0.7 
0.7 
0.6 
0.7 
I 
Triacylglycerol 
Protein 
1 hour° 
4 hour" 
fasted^fU 
mean 
8.8 11.4 14.5 2.8 8.5 14.6 2.3 
14.6 15.3 26.1 4.6 13.8 24.1 3.7 
11.0 14.0 17.5 3.6 10.9 18.1 3.0 
11.7® 13.5® 19.4b 3.7 11.0® 
Q 00 00 H 3.0 
1 hour^ 
4 hourC 
fasted" 
mean 
1.2 
1.6 
4.5 
2.4 
1.2 
3.4 
6.5 
3.7 
0.4 
0.5 
2 . 2  
1.3 
0.7 
1.9 
0.3 
0.4 
1.8 
1.1 
^Table is separated into type of fat effects and amount of fat effects. 
Times are separated into length of time after the meal. H 
M 
^T=tallow, B=50:50 (wt:wt) blend of tallow and soy oil, SO=soy oil. ^ 
^20%=20% of calories as fat, 40%=40% of calories as fat. 
^Means with the different superscript letters (a and b) in a row within type 
or amount of fat differ (P<0.05). 
c 
SEM=standard error of the mean. 
^Refers to time after a meal. Fasted refers to samples taken 12 hours 
after the previous meal. Times with different superscript letters (c and d) 
within a component of the lipoprotein are different over all fat sources (P<0.05). 
^n for 12-hour cholesterol samples: T=6, B=5, S0=7; 20%=7, 40%=9. 
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hours after feeding tended to have a greater concentration of 
both free and total cholesterol. Redgrave and Carlson (1979) 
noted increased VLDL-total cholesterol 6 hours 
postprandially. No change in concentration of VLDL-
phospholipid occurred, which was also in agreement with 
Redgrave and Carlson (1979). 
Concentration of triacylglycerol in the VLDL/chylomicron 
fraction was affected by time after feeding, type of fat, and 
amount of fat in the diet (Table 4). Triacylglycerol 
concentration was increased 4 hours postprandially when 
compared with that in samples taken 1 hour postprandially 
(P<0.05); however, concentrations in samples taken 4 hours 
postprandially were not different from those in "fasted" 
samples (P=0.16). This effect occurred because those pigs 
that received 20% of calories as the blended fat had lower 
concentrations of triacylglycerol than would be expected. If 
values from these pigs are deleted, the concentration of 
VLDL-triacylglycerol from fasted animals are lower than those 
from pigs at 4 hours after feeding. It may be that the pigs 
fed 20% of calories as a blend of fats had a depressed 
lipemic response because of low fat intake or some other 
protective mechanism. Pigs fed diets enriched with soy oil 
had significantly greater concentrations of triacylglycerol 
in the VLDL/chylomicron fraction (P<0.05) than did pigs fed 
diets containing tallow or a blend of tallow and soy oil. 
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Reasons for this are unknown but may be because of depressed 
HDL concentration in the soy oil-fed pigs. An increase in 
amount of fat in the diet also increased triacylglycerol 
concentrations in VLDL/chylomicron concentrations, as would 
be expected. 
Effects on Plasma 
Table 5 shows the composition of plasma components as 
affected by time after a meal and type and amount of dietary 
fat and is therefore a compilation of all lipoprotein 
subfractions. Concentrations of free and total cholesterol 
in plasma were not affected by feeding when compared with 
concentrations in fasted samples. Olefsky et al. (1976) also 
saw no postprandial increase in concentration of free and 
total cholesterol in humans. In contrast, Groot and Scheek 
(1984) and Tall et al. (1982) reported a postprandial 
increase in concentration of plasma total cholesterol at 6 
and 8 hours after a meal. Possibly, the samples collected 6 
to 8 hours postprandially in my study would have had elevated 
concentrations of plasma total cholesterol. Pigs fed 40% of 
calories as fat did have higher concentrations of free and 
total cholesterol in plasma (P<0.05) than did pigs fed 20% of 
calories as fat. Work done by Siebert et al. (1987) is in 
agreement with observations that increased fat intake 
increased concentration of plasma total cholesterol. Type of 
fat had no effect on plasma cholesterol concentration, 
Table 5. Composition of plasma as affected by type and amount of dietary fat and 
time after feeding^ 
Type of fat^ Amount of fat" 
4 Component T B SO SEM^ 20% 40% SEM^ 
Free cholesterol 
1 hour^ 18.9 18.1 19.6 1.9 15.6% 22.1% 1.5 
4 hour 18.3 16.5 20.9 2.2 15.6% 21.6^ 1.8 
fasted 18.7 21.1 17.4 2.6 17.1 21.0^ 2.2 
mean 18.7 18.5 19.3 2.3 16.0^ 21.5° 1.9 
Total cholesterol 
1 hour 73.3 79.0 71.6 4.8 65.7* 83.6% 3.9 
4 hour 70.9 70.4 72.6 11.2 62.4* 80.3* 9.2 
fasted 76.2 87.1 74.8 6.0 69. 5* 89:2° 4.9 
mean 73.9 79.2 73.0 5.5 65.9* 
Q 1
"^ 
CO 4.5 
Phospholipid 
1 hour^ ^ 81.5 76.7 86.7 9.2 66.6* 96.7% 7.5 
4 hour°' ^ 84.5 93.0 100.0 6.4 76.9* 108.6° 4.4 
fasted* 120.2 105.1 101.6 19.2 109.5 108.4 15.6 
mean 96.9 92.6 91.4 14.7 84.7* 102.2° 12.0 
Triacylglycerol 
1 hour^ 
4 hour" 
fasted^ 
mean 
35.3 
47.0 
43.7 
42.0 
32.9 
57.9 
40.9 
44.5 
41.9 
75.2 
37.4 
51.2 
5.6 
13.2 
8 . 0  
9.5 
31.1 
41.8® 
37.3 
37.5® 
42.2^ 
76.0° 
44.1^ 
54.lb 
4.5 
10.8 
6 . 6  
7.8 
Protein -g/dL-
1 hour 
4 hour 
fasted 
mean 
7.7 
7.7 
6 . 8  
7.5 
6.7 
7.5 
7.2 
7.2 
7.9 
8.3 
7.0 
7.7 
0 . 6  
0.3 
0 . 6  
0 . 6  
7.4 
7.4 
6.5 
7.1 
7.5 
8.3 
7.4 
7.8 
0.5 
0.3 
0.5 
0.5 
^Table is separated into type of fat effects and amount of fat effects. 
Times are separated into length of time after the meal. 
^T=tallow, B=50:50 (wtiwt) blend of tallow and soy oil, SO=soy oil. 
^20%=20% of calories as fat, 40%=40% of calories as fat. 
^Means with the different superscript letters (a and b) in a row within type 
or amount of fat differ (P<0.05). 
5 SEM=standard error of the mean. 
^Refers to time after a meal. Fasted refers to samples taken 12 hours after 
the previous meal. Times with different superscript letters (c and d) within a 
component of the lipoprotein are different over all fat sources (P<0.05). 
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possibly because of the protective action of stearic and 
oleic acids in beef tallow (Bonanome and Grundy, 1988). 
Concentration of phospholipid in plasma of pigs was 
decreased at 1 hour but not at 4 hours after a meal (Table 
5). Pigs fed 20% of calories as fat had lower concentrations 
of phospholipid in the plasma 1 and 4 hours postprandially 
and over all times than did pigs fed 40% of calories as fat. 
This may be because of increased concentrations of 
circulating lipoproteins in pigs fed high fat diets. 
Concentration of plasma triacylglycerol was increased at 
4 hours but not at 1 hour after feeding. Redgrave and 
Carlson (1979) noted increased plasma triacylglycerol 6 hours 
after a meal but not 3 hours after a meal. In contrast, 
Groot and Scheek (1984) saw the greatest increase in 
concentration of triacylglycerol in plasma 3 hours 
postprandially, but concentration of triacylglycerol in 
plasma had decreased to basal concentrations by 8 hours after 
a meal. Tall et al. (1982) noted that concentration of 
triacylglycerol in plasma was highest 5 hours postprandially 
and had not yet returned to pre-meal concentrations by 8 
hours after a meal. In my study, again, an increased amount 
of fat in the diet increased concentrations of plasma 
triacylglycerol; this effect was especially prominent at 4 
hours postprandially. The majority of the increase in the 4-
hour samples was from the VLDL/chylomicron fraction, as would 
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be expected. 
Concentration of protein in plasma was not affected by 
time after feeding, type of dietary fat, or amount of dietary 
fat (Table 5). 
Summary 
In summary, in the LDL fraction the concentration of 
phospholipid was decreased 4 hours after a meal. The 
concentrations of LDL-free and total cholesterol were 
increased when pigs were fed 40% of calories as fat. In HDL, 
concentration of triacylglycerol was increased and 
concentrations of phospholipid and protein were decreased 
postprandially. Concentrations of HDL-total cholesterol and 
-phospholipid were increased when high fat diets were fed. 
Diets containing soy oil increased concentration of 
triacylglycerol in VLDL. Postprandially, concentration of 
VLDL-protein was decreased and concentration of VLDL-
triacylglycerol generally was increased. 
In conclusion, when all times were combined, type and 
amount of fat differentially affected the composition of 
lipoproteins in pigs. Amount of dietary fat had a greater 
effect than did type of dietary fat. Lipoprotein composition 
also changed postprandially, but the change was not greatly 
affected by type of dietary fat. Amount of dietary fat, 
however, did alter the changes that occur in lipoproteins 
postprandially. In general, postprandial lipoproteins do not 
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seem to be more atherogenic than are lipoproteins in the 
fasting state in this study. The possible exception may be 
chylomicron remnants. Concentration and composition of HDL 
probably play an important role in protecting the body 
against the atherogenic effects of the triacylglycerol-rich 
particles. 
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SECTION IV. CHOLESTEROL CONVERSION INTO BILIARY 
CHOLESTEROL AND BILE ACIDS AND DEPOSITION 
INTO TISSUES OF PIGS AS INFLUENCED BY DIETARY 
FAT SOURCE 
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ABSTRACT 
The Study presented herein fed pigs (as a model for 
humans) diets that mimicked the ranges of human intakes of 
quantity and quality of fats in an effort to determine the 
effects on cholesterol conversion into biliary cholesterol 
and bile acids and deposition into tissues. Young growing 
pigs were fed diets containing either 20% or 40% of calories 
as fat, primarily either beef tallow, soy oil, or a 50:50 
(wtzwt) blend of tallow and soy oil in a 2 X 3 factorial 
design. During week 4, common bile duct, duodenal, and 
femoral arterial catheters were implanted into pigs. After 
week 6, each pig was injected with autologous low-density 
lipoprotein containing H-cholesterol. Total bile output was 
collected, and serial bile samples were collected for 24 
hours. Dietary fat source did not affect bile flow rate or 
concentrations of total bile acids, cholesterol, or 
phospholipids in bile. Biliary cholesterol and phospholipids 
tended to be increased in pigs fed 40% of calories as fat 
when compared with pigs fed 20% of calories as fat. Pigs 
3 
secreted an average of 16.2% of injected dose of H-
cholesterol into bile as bile acids and 4.5% of injected dose 
as biliary cholesterol during the 24-hour period. No 
significant treatment effects were observed other than a 
significant type-by-amount interaction of dietary fat 
(P=0.05). No significant treatment effect was observed for 
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concentration of lipid in heart, liver, skeletal muscle, 
perirenal or subcutaneous adipose tissue, or total carcass. 
Pigs fed 40% of calories as fat had a higher percentage lipid 
in the aorta and gastrointestinal tract than did pigs fed 20% 
of calories as fat. Concentration of cholesterol in liver 
was greater in pigs fed tallow than in pigs fed a blend of 
tallow and soy oil; concentrations of cholesterol in other 
tissues were not influenced by treatment. Pigs fed 20% of 
calories as fat had greater percentage of injected dose of 
^H-cholesterol deposited in heart and muscle than did pigs 
fed 40% of calories as fat. Soy oil-fed pigs had greater 
deposition of ^H-cholesterol into perirenal adipose tissue 
than did pigs fed diets containing tallow or a blend of 
tallow and soy oil. In conclusion, type and amount of 
dietary fat did not affect concentration of biliary 
cholesterol, bile acids, or phospholipids. The effects of 
fat source on concentration of cholesterol and total lipid or 
deposition of LDL-cholesterol in tissues were inconsistent. 
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INTRODUCTION 
Relatively high concentrations of low-density 
lipoprotein (LDL)-cholesterol have been implicated in being a 
causative factor for atherosclerosis. Diet, especially type 
and amount of dietary fat, can influence strongly the 
concentration of LDL-cholesterol in plasma; saturated fatty 
acids that are 12-16 carbons in length are 
hypercholesterolemic and monounsaturated and polyunsaturated 
fatty acids are hypocholesterolemic (see McNamara, 1987 for 
review). The exact role that dietary fats play in control of 
plasma cholesterol concentration,is yet to be elucidated and 
may involve cholesterol synthesis or excretion. 
Excretion of cholesterol from the body is primarily 
through secretion into bile as biliary cholesterol and bile 
acids and subsequent loss of these compounds into feces. 
Several dietary factors can affect biliary concentration of 
lipids. Researchers have shown that a diet high in 
polyunsaturated fatty acids increased biliary cholesterol 
excretion (Gonzales et al., 1989; Balasubramaniam et al., 
1985) and biliary bile acid excretion (Ramesha et al», 1980; 
Byers and Friedman, 1958). This may be one way that 
polyunsaturated fats cause the hypocholesterolemia associated 
with the ingestion of these fats. 
In addition, concentration of plasma cholesterol may be 
decreased when subjects ingest polyunsaturated fatty acids 
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for a period of time because plasma cholesterol is taken up 
more rapidly into several tissues, including liver. 
Cholesterol received by the liver may have one of many fates. 
For example, it may be used as a substrate for bile acid 
synthesis, secreted directly into bile as biliary 
cholesterol, stored in the cell as cholesteryl ester, or used 
as structural components for cell membranes. 
Pigs are an excellent model for humans when studying 
etiology and prevention of coronary heart disease because 
pigs can consume diets similar to human diets, are 
anatomically and physiologically similar to humans, and 
develop spontaneous hypercholesterolemia and atherosclerosis 
(Phillips and Tumbleson, 1986). Because they are excellent 
models for humans, pigs were used in this study to test the 
hypothesis that the amount and fatty acid composition of 
dietary fats affect the rate of clearance of cholesterol from 
plasma and secretion of cholesterol into bile as bile acids 
or biliary cholesterol. The specific objectives of this 
study were to determine the effect of type and amount of 
dietary fat on 1) amount of LDL-cholesterol transfered to 
bile as cholesterol or as bile acids or that is deposited in 
tissues, 2) concentration of cholesterol, bile acids, and 
phospholipids in bile of pigs and, 3) LDL-cholesterol 
deposition, percentage of lipid, and concentration of 
cholesterol in several tissues. 
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MATERIALS AND METHODS 
Thirty crossbred, castrated male pigs, approximately six 
weeks of age, were used. Pigs were assigned randomly to one 
of the six diets shown in Table 1. Pigs were housed in an 
environmentally controlled building in individual pens on 
concrete floors covered with sawdust. Water was supplied ad 
libitum from automatic nipple waterers. Pigs were weighed 
weekly, and feed intake was adjusted to 4% of body weight on a 
dry-matter basis. 
Diets (Table 1) were fed in a completely randomized, 2 X 
3 factorial design with two amounts and three types of fat. 
Amounts of dietary fat were either 20 or 40% of calories as 
fat; types of supplemental dietary fat were tallow, soy oil, 
or a 50:50 (wtzwt) blend of tallow and soy oil. Ground beef 
and soy protein isolate were used as protein sources to mimic 
a typical American diet. Crystalline cholesterol was added to 
diets as needed to equalize cholesterol intakes. Cholesterol 
was dissolved in the dietary fat source and then combined with 
other dietary ingredients. Pigs were fed two times daily for 
six weeks. Gross energy of the diets was verified by bomb 
calorimetry (Par Oxygen Bomb Calorimeter, Model 1241, Parr 
Instrument Co., Inc., Moline, IL). The high fat diets 
contained 3,900 kilocalories, and the low fat diets contained 
3,500 kilocalories of metabolizable ener^ per kilogram of 
feed. Protein content of the diets was determined by the 
Table 1. Ingredient composition of diets^ 
Diet 
Ingredient 20% T 20% SO 20% B 40% T 40% SO 40% B 
% of dry matter 
Ground shelled com 75.9 75.3 75.4 57.2 56.6 56.8 
Soy protein isolate^ 9.5 9.3 9.5 13.1 12.6 12.8 
Ground beef^ 4.6 4.5 4.6 6.4 6.1 6.2 
Soy oil^ - 10.3 5.0 - 24.1 11.7 
Tallow® 9.4 — 5.0 22.7 - 11.7 
Vitamins and minerals^ 0.6 0.6 0.6 0.6 , 0.6 0.6 
Crystalline cholesterol^ 14.6 23.3 18.7 — 20.7 10.0 
(mg/100 g feed) 
^Abbr. : 20% and 40% refer to amount of calories as fat based on metabolizcible 
energy from fat, T = Tallow, SO = Soy oil, B = Blend of tallow and soy oil. 
^Supro 620, Ralston Purina Co., St. Louis, MO. 
^Carriage House Meat and Provision Co., Ames, lA. 
^Central Soya Co., Inc., Fort Wayne, IN, donated through the courtesy of D. 
Strayer. 
®Iowa State University Meat Laboratory, Ames, lA. 
^Feed Specialties Co., Des Moines, lA, donated through the courtesy of L. 
Russell. Guaranteed analysis (per kg.); 150 mg retinyl palmitate, 1.24 mg 
cholecalciferol, 900 mg dl-alpha-tocopheryl acetate, 136 mg menadione (synthetic 
vitamin K), 225 mg riboflavin, 1,360 mg niacin, 900 mg d-pantothenic acid, 23,700 
mg choline chloride, 1.1 mg cobalamin, and 40 mg folic acid. Mieral sources were 
calcium carbonate, sodium selenite, manganese sulfate, iron sulfate, calcium 
iodate, copper oxide, zinc oxide, magnesium oxide, and iron oxide. This premix 
was added at a rate of 50 g/10 kg feed, as-fed basis. 
^Sigma Chemical Co., St. Louis, MO. 
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Kjeldahl method. On a dry-matter basis, low fat diets 
contained 15.9% crude protein and high fat diets contained 
17.6% crude protein. A vitamin and mineral premix was added 
to meet or exceed daily requirements for growing pigs (NRC, 
1979). Fatty acid composition of the diets was determined by 
gas-liquid chromatography-mass spectrometry (Hewlett-Packard 
5890/5790a, Avondale, PA) (Lepage and Roy, 1986) and is shown 
in Section II of this dissertation. 
During week 4, each pig was fitted with a bile duct 
catheter and duodenal catheter according to the method 
outlined in Section II of this dissertation. Bile flow was 
checked daily during recovery until sample collection. The 
survival rate for the surgical procedure was 88% (30 of 34 
pigs survived). 
During the same surgery, pigs were fitted with femoral 
arterial catheters. The catheter was placed such that its 
tip extended into the thoracic aorta. The other end of the 
catheter was threaded subcutaneously from the inside of the 
hind leg to the top of the back behind the shoulder. Patency 
of the catheter was maintained by flushing the catheter every 
other day with a sodium heparin solution (192 U/mL) in 0.15 M 
NaCl solution. Other 6-week-old pigs were implanted with 
common bile duct and duodenal catheters. Bile from these 
pigs was collected daily and stored at 4°C until needed for 
reinfusion into test pigs. The bile-donor pigs were fed 
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treatment diets and maintained until catheter failure. 
During week 4, 240 mL of blood were collected from each 
pig by orbital sinus puncture (Huhn et al., 1969). After 
collection, the blood was centrifuged to separate plasma; 
Plasma was subjected to ultracentrifugation after density-
adjustment (Havel et al., 1955) to separate LDL. The LDL 
(approximately 75 mL) was labeled with [la, 2a(n)-^H] 
cholesterol, specific activity 44.7 Curies/mmol (Amersham, 
Arlington Heights, IL) by the method of Schwartz et al. 
(1978). 
At the end of the 6-week feeding period, the labeled LDL 
was injected into the pigs via the femoral arterial catheter. 
An injection of 60 ml of previously collected whole blood 
from the same pig followed to insure that all labeled LDL 
solution was removed from the catheter and had entered the 
aorta. The time from blood collection for harvest of LDL to 
injection of radiolabeled LDL was 2 weeks. 
Serial bile samples then were collected at 5, 15, 30, 
and 45 minutes and at 1, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 
22, and 24 hours post-injection. A 10-mL aliquot of bile was 
collected and stored at -20°C until analysis. Bile was 
allowed to flow freely into glass containers for measurement 
of the volume secreted between samplings. An aliquot of the 
pooled bile was taken and stored at -20°C until analysis. 
Nonradioactive bile that was collected previously from bile-
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donor pigs was pumped into the duodenal catheter of the 
treated pigs at a rate approximately equal to their bile flow 
rate to maintain normalcy with regard to bile acid 
metabolism. During the sampling period, pigs were fed the 
treatment diet every 2 hours to keep pigs in a steady state 
with regard to digestion, absorption, and bile lipid 
profiles. 
After the 24-hour collection period, pigs were killed by 
injection of 10 mL of a 5% solution of thiamylal sodium 
(Parke-Davis, Morris Plains, NJ) to induce anesthesia, which 
was followed by exsanguination. Tissue samples from liver, 
aorta, perirenal and subcutaneous adipose tissues, heart, 
carcass minus brain and spinal cord, Longissimus dorsi, and 
gastrointestinal (GI) tract minus esophagus and accessory 
organs were collected. All tissues were stored at -20°C 
until analysis. 
The extraction method of Bligh and Dyer (1959) was used 
to separate a 1-mL aliquot of bile into aqueous (containing 
bile acid) and organic (containing cholesterol) fractions by 
using 1.0:2.0:0.8 (chloroform:methanol:water) as the 
extraction solvent. Recoveries were verified by adding both 
^H-cholesterol and ^^C-cholic acid to nonradioactive bile 
samples, extracting each sample, and measuring radioactivity 
in the aqueous and organic phases by using dual-label liquid 
scintillation counting techniques. By using this procedure. 
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97% of the ^H-cholesterol was recovered in the organic phase 
and 96% of the ^ ^C-cholic acid was recovered in the aqueous 
phase. Total radioactivity in the organic phase of samples 
taken from pigs on treatment was determined after evaporating 
to dryness and redissolving in scintillation cocktail (Ready-
Solv EP, Beckman Instruments, Inc., Fullerton, CA). Aliquots 
(1 mL) from the aqueous phase were mixed with scintillation 
cocktail and counted. 
Bile samples were analyzed for concentrations of 
cholesterol, bile acids, and phospholipids. Biliary 
cholesterol was determined enzymatically by the technique of 
Luhman et al. (1990) that uses pretreatment with bilirubin 
oxidase. Concentration of total bile acids was determined 
enzymatically by using 3a-hydroxysteroid dehydrogenase (HSD). 
Cholic acid was used as the standard. In this assay, the 
reaction of HSD with bile acids produces reducing equivalents 
that are transferred by the action of diaphorase to nitroblue 
tetrazolium, causing blue color formation in proportion to 
the concentration of bile acids present. Concentration of 
biliary phospholipids was determined enzymatically by the 
method of Takayama et al. (1977), which detects choline-
containing phospholipids. In bile, phosphatidylcholine 
comprises 95% of the phospholipids secreted (Kwamoto et al., 
1980). 
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• Liver, GI tract, carcass, and heart were ground in a 
meat grinder. Aorta, Longissimus dorsi, and perirenal and 
subcutaneous adipose tissues were ground in a Waring blender 
after freezing in liquid nitrogen. Total lipid was extracted 
from a 500-mg sample of lyophilized tissue according to the 
technique of Bligh and Dyer (1959), evaporated to dryness and 
quantified gravimetrically. The dried samples were 
redissolved in either isopropanol or scintillation cocktail. 
Total radioactivity of ^H-cholèsterol in tissues was measured 
by.liquid scintillation counting. Liver, aorta, GI tract, 
heart, and Longissimus dorsi samples that were redissolved in 
isopropanol were assayed for concentration of total 
cholesterol enzymatically (Sigma Cholesterol Kit No. 352, 
Sigma Chemical Co., St. Louis, MO). Gastrointestinal tract 
and Longissimus dorsi muscle samples developed cloudiness 
that interfered with the assay; these samples required 
filtering with 0.22 fm filters (Millipore, Bedford, MA) 
before reading absorbance on the spectrophotometer. 
The analysis of variance was determined by using the 
general linear model (GLM) procedure of SAS (1982) and tested 
the effects of type and amount of dietary fat and for 
interaction between them. Orthogonal contrasts were used to 
compare the means of dietary treatments. 
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RESULTS AND DISCUSSION 
The results of the first 6 weeks of the feeding period 
were reported by Faidley et al. (1990). Briefly, pigs fed 
diets containing 20% of calories as fat, primarily as soy 
oil, gained less body weight then did pigs fed 40% of 
calories primarily as soy oil or the blend of tallow and soy 
oil. Different dietary fats did not affect concentrations of 
cholesterol, triacylglycerol, or protein in plasma or major 
lipoprotein fractions. Concentration of phospholipid was 
less in plasma and very low-density lipoprotein of pigs fed 
diets containing soy oil. Weight percentage of cholesteryl 
ester was decreased in pigs fed diets high in soy oil when 
compared with pigs fed diets high in tallow. 
There were no effects of diet on bile flow (P>0.05, 
Table 2). Bile flow averaged 1.05 mL/hour*kilogram body 
weight for all pigs. The pigs secreted an average of 56.6 
mL/hour (1.4 L per 24 hours). Juste et al. (1983a) reported 
that pigs weighing 50 kg secreted approximately 2.6 L (108 mL 
per hour) of bile in a 24-hour period and that flow rate was 
variable throughout the collection period. Sambrook (1981) 
reported a large variation in flow between and within pigs; 
flow rate was 1.5 L per 24 hour period for pigs weighing 25-
30 kg. Juste et al. (1979) reported that pigs weighing 45 kg 
secreted 2.1 L of bile in 24 hours. Laplace and Ouaissi 
Table 2. Effect of type and amount of dietary fat on bile parameters 
Diet^ 
Parameter 20T 2 OB 20SO 40T 4 OB 40SO SEM*) 
Bile flow 
(mL/hr-kg BW®) 
0.93 1.04 1.08 1.04 1.03 1.20 0.14 
Bile acid 
(mmol/L) 
(mmol/24 hours) 
49.2 
60.2 
50.1 
57.1 
56.3 
78.4 
54.6 
79.7 
48.1 
69.3 
42.6 
63.5 
4.2 
5.9 
Cholesterol 
(mmol/L) 
(mmol/24 hours) 
1.21 
1.48 
1.03 
1.17 
1.15 
1.60 
1.45 
2.12 
1.10 
1.58 
1.32 
1.97 
0.21 
0.29 
Phospholipid 
(mmol/L) 
(mmol/24 hours) 
7.82 
9.57 
7.24 
8.25 
6.95 
9.67 
7.71 
11.26 
7.66 
11.03 
9.48 
14.13 
1.32 
1.85 
^T=tallow, B=50:50 (wt:wt) blend of tallow and soy oil, SO=soy oil; 20=20% of 
calories as fat, 40=40% of calories as fat. 
^SEM=standard error of the mean, SEM for flow data calculated with harmonic 
mean of 4.3 because n=4 for 20T, 2OB, 20SO, and 40T; n=5 for 403 and 40SO. 
°BW=body weight. 
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(1979) found that in larger pigs (60 kg) bile flow was 
about 2 L in 24 hours and varied only postprandially. 
Juste et al. (1983b) reported that pigs fed 2% lard 
in the diet secreted less bile than did pigs fed 10% or 20% 
lard in the diet. There was no difference between their 
pigs fed 10% or 20% lard diets. Bile flow from the pigs in 
my study was not increased when 40% of calories as fat was 
fed when compared with pigs fed 20% of calories as fat. It 
may be that bile flow rates reach a maximum at 10%-20% 
dietary fat, thus explaining the lack of an effect of 
dietary fat source in pigs in my experiment. It is also 
possible that feeding small meals every two hours removed 
the effect of feeding or fat source on bile flow. Jones 
and Grossman (1969) reported that the size of a meal had a 
direct effect on choleresis in dogs, with meal size being 
directly proportional to volume of bile secreted. 
There were no effects of diet on concentrations of 
total bile acids, cholesterol, or phospholipids in bile 
(P>0.05, Table 2). Juste et al. (1983b) reported average 
concentrations of biliary bile acids, cholesterol, and 
phospholipids in pigs of 49.9 mmol/L, 0.8 mmol/L, and 4.5 
mmol/L, respectively. They also reported an increase in 
biliary cholesterol and phospholipid with increased 
concentration of fat from 2% to 10% in the diet, but no 
increase in biliary bile acids occurred when diets having 
152 
greater then 10% lard were fed. However, biliary 
concentrations of cholesterol and phospholipid did increase 
in pigs fed 20% of calories as fat when compared to pigs 
fed 10% of calories as fat; concentrations of fat greater 
than 20% of calories were not measured. 
In other species, Ramesha et al. (1980) and Byers and 
Friedman (1958) reported bile flow and biliary 
concentration of cholesterol and bile acids in rats were 
increased following ingestion of a highly unsaturated fat. 
In contrast, Boquillon and Clement (1979) noted no increase 
in bile flow or concentration of biliary bile acids but an 
increase in concentration of biliary cholesterol and 
phospholipids when corn oil was fed to rats. In addition, 
Balasubramaniam et al. (1985) reported an increased 
secretion of biliary cholesterol in rats fed fish oils. 
Admirand and Small (1969) used triangular coordinates 
as a method of representing biliary lipid composition (bile 
acids, cholesterol, and phospholipids). This method 
allowed calculations of the maximal concentration of 
cholesterol that can be solubilized in bile to prevent 
precipitation of cholesterol as gallstones. The authors 
reported values for human subjects with no apparent 
cholelithiasis of approximately 73% bile acids, 5% 
cholesterol, and 22% phospholipids in biliary lipids. In 
the pigs reported in my study, the percentage of biliary 
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lipids were 77.6% bile acids, 1.8% cholesterol, and 20.5% 
phospholipids. Pigs have relatively low molar percentages 
of biliary cholesterol and thus do not form cholesterol 
gallstones spontaneously but, in other respects, are very 
similar to humans in terms of biliary composition. 
No significant treatment effects were noted for 
percentage of ^H-cholesterol administered in LDL that was 
secreted into bile as bile acids or as biliary cholesterol 
(Table 3). Averages of 16.2% and 4.5% of injected dose 
were secreted in bile as bile acids and cholesterol, 
respectively, in 24 hours. For comparison. Galloway et al.. 
(1990) reported 24.6% of injected dose secreted as bile 
acids and 5.6% of injected dose secreted as biliary 
cholesterol after 48 hours in pigs fed diets varying in 
amount of calcium and cholecalciferol. Dupont et al. 
(1974) infused labeled cholesterol into the jejunum of pigs 
and reported that bile acid synthesis from radiolabeled 
cholesterol occurred within 15 minutes after 
administration, reached a maximum within 6 hours, and then 
maintained equilibrium for several days. The percentage of 
label excreted as bile acids were not as high as expected; 
the ratio of ^H-bile acids to ^ H-cholesterol in the bile 
was 3.6:1, whereas the ratio of bile acids to cholesterol 
in bile was 43.3:1. It may be that ^H-cholesterol was 
selectively excreted into bile as cholesterol without 
Table 3. Effect of type and amount of dietary fat on percentage of injected 
dose of ^H-cholesterol in LDL secreted into bile during 24 hours after 
inj ection 
Diet^ 
Biliary constituent 20T 20B 20SO 40T 40B 40SO SEM^ 
Bile acid*^ 15.2 H m H 12.0 10.9 26.8 19.1 6.5 
Cholesterol*^' ® 3.8 4.6 5.1 6.6 3.6 3.5 1.0 
n 4 3 5 5 4 4 
®T=tallow, B=50:50 (wttwt) blend of tallow and soy oil, SO=soy oil; 20=20% of 
calories as fat, 40=40% of calories as fat. 
^SEM=standard error of the mean, SEM calculated with harmonic mean of 4.2. 
^Percentage of injected ^H-cholesterol in LDL secreted into bile as bile acids. 
'^Percentage of injected ^H-cholesterol in LDL secreted into bile as 
cholesterol. 
^Significant interaction of type of fat X amount of fat (P=0.05). 
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conversion to bile acids because it was primarily as free 
cholesterol on the surface of LDL. 
Several studies on the effects of bile metabolism on 
blood cholesterol concentration and homeostasis have been 
completed (Nervi et al., 1984; Ramesha et al., 1980). An 
understanding of how biliary lipids are regulated is 
essential because bile acid and cholesterol secretion into 
bile and possible subsequent excretion from the body via 
feces is the major excretory route of cholesterol from the 
body. Diet may play a role in cholesterol conversion to bile 
acids or cholesterol secretion into bile (see Liepa and 
Sullivan-Gorman, 1986 for review). In the study presented 
here, diet did not influence greatly the concentration of 
biliary lipids in pigs. It is possible that the fatty acids 
profile of tallow is not as conducive to changing biliary 
lipid composition as are other saturated fatty acid sources. 
Several other possible reasons as to why dietary fat 
source did not affect biliary lipid secretion and 
concentration in this study should be considered. As alluded 
to, the lowest amount of fat fed (20% of calories as fat) may 
be above the maximal amount of dietary fat that pigs can 
respond to with changes in bile composition. Pigs fed 
treatment diets of 5% and 20% of calories as fat rather than 
20% and 40% of calories as fat may have had differences in 
bile flow and composition because of dietary fat source. 
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Einarsson et al. (1989) have shown in humans that 7a-
hydroxylase, the rate-limiting enzyme in bile acid synthesis, 
can be saturated or limited by availability of cholesterol in 
liver microsomes. In addition, Dowling et al. (1970) 
reported that maximal bile acid production rate can be 
reached if enterohepatic circulation of bile acids is 
compromised. These researchers noted that, beyond a point, 
bile acid production plateaus and can not be increased 
further. 7a-Hydroxylase in pigs may be more readily 
saturable under the influence of different dietary 
conditions; thus, production of bile acids may have reached a 
maximum in pigs in my study. 
Another possibility may be that the pigs in my trial had 
adapted to diets. Pigs had been fed test diets for 6 weeks 
before bile samples were collected. Other research 
reportedly used animals fed treatment diets for a maximum of 
3 weeks (Boquillon and Clement, 1979; Juste et al., 1983b). 
The third possible reason for lack of effect of diet on 
bile composition is that pigs were modified surgically so 
that the gall bladder was no longer functional. This is 
unique to my surgical model in pigs. The gall bladder can 
alter biliary composition and may be influenced 
differentially by dietary fat source. Fisher et al. (1987) 
showed that meal composition differentially affects gall 
bladder emptying in humans. Bile composition may be affected 
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similarly. In addition, pigs in my study had bile reinfused 
into the duodenum. Juste et al. (1983a) noted that bile acid 
concentration in bile increased if bile was reinfused into 
the common bile duct rather than into the duodenum. 
Lastly, the pigs used in my study were restricted in 
amount of feed consumed rather than allowed ad libitum 
intake. Pattison and Chapman (1986) reported that biliary 
lipid concentration increased with feeding and decreased with 
fasting; biliary cholesterol was most affected. In addition, 
Ferland et al. (1989) reported that rats fed 60% of ad 
libitum intake generally had greater cholic acid secretion 
into bile than did those fed ad libitum. Continued research 
on effects of diet on bile acid and biliary cholesterol 
metabolism as it relates to cholesterol homeostasis is 
essential. 
There was no significant treatment effect on 
concentration of cholesterol in aorta, heart muscle, or GI 
tract (Table 4). Pigs fed diets containing tallow had higher 
concentration of cholesterol in liver samples (P<0.10) then 
did pigs fed diets containing a blend of tallow and soy oil. 
Cholesterol concentration in liver of pigs fed diets 
containing soy oil was not different from that of pigs fed 
diets containing the other fat sources. Likewise, Baldner-
Shank et al. (1987) reported that type of fat had little 
effect on concentration of cholesterol in tissues. Walsh et 
Table 4. Effect of type and amount of dietary fat on concentration of cholesterol, 
percentage of lipid, and percentage of injected dose of ^H-cholesterol 
deposition in tissues 
Diet^ 
Tissue 20T 2 OB 20SO 40T 40B 40SO SEM^ 
Aorta 
cholesterol 
(mg/g DM) 
% lipid* 
% dose/g DM 
4.7 
12.4 
0.022 
5.4 
18.8 
0.025 
5.3 
13.0 
0.053 
6.1 
19.6 
0.011 
6.7 
23.2 
0.018 
8.5 
20.6 
0.044 
1.4 
3.9 
0.020 
Heart muscle 
cholesterol 
(mg/g DM) 
% lipid 
% dose/g DM* 
5.9 
10.8 
0.021 
6.4 
13.2 
0.018 
6.5 
11.4 
0.027 
6.3 
12.0 
0.017 
5.8 
10.6 
0.016 
6.3 
12.2 
0.016 
0.3 
2.2 
0.004 
Liver g 
cholesterol 
(mg/g DM) 
% lipid 
% dose/g DM 
8.1 
10.4 
0.072 
7.2 
10.0 
0.054 
7.7 
9.4 
0.076 
8.9 
11.0 
0.075 
7.4 
9.6 
0.082 
8.3 
10.2 
0.051 
0.5 
0.7 
0.019 
L. dorsi 
cholesterol 
(mg/g DM) 
% lipid 
% dose/g DM* 
2.6 
12.0 
0.009 
2.6 
15.4 
0.062 
2.1 
12.6 
0.029 
2.6 
12.4 
0.007 
2.8 
13.6 
0.010 
2.6 
12.2 
,0.010 
0.6 
4.4 
0.017 
GI tract 
cholesterol 
(mg/g DM) 5.7 5.8 6.7 6.0 7.0 6.5 1.7 
% lipid® 38.2 31.8 31.8 37.6 39.2 40.0 2.5 
% dose/g DM 0.014 0.014 0.024 0.036 0.013 0.016 0.024 
3 Perirenal adipose 
% lipid 88.6 87.6 88.6 . 91.8 90.2 . 87.6 . 1.7 
% dose/g DM' 0.010^ 0.022^'° 0.079° 0.005® 0.023®' 0.055°'° 0.001 
3 Subcutaneous adipose 
% lipid 85.2 86.6 80.2 79.0 88.0 82.4 3.8 
% dose/g DM 0.006 0.012 0.020 0.016 0.013 0.031 0.009 
3 Carcass 
% lipid 47.2 48.4 41.4 45.2 47.4 44.0 3.0 
% dose/g DM 0.007 0.006 0.012 0.010 0.008 0.007 0.003 
^T=taliow, B=50;50 (wt;wt) blend of tallow and soy oil, SO=soy oil; 20=20% of 
calories as fat, 40=40% of calories as fat. 
^SEM=standard error of the mean, SEN for % dose calculated with harmonic mean 
of 4.7 because n=4 for 20B and 40B; n=5 for 20T, 20SO, 40T, and 40SO. 
^Concentration of cholesterol not determined on these samples. Carcass does 
not include viscera, brian, or spinal cord. 
^Amount of fat effect (P<0.10). 
^Type of fat effect (P<0.10). 
®Amount of fat effect (P<0.05). 
^Type of fat effect (P<0.001). 
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al. (1983) and Barrows et al. (1980), however, reported an 
increase in the concentrations of cholesterol in liver of 
pigs and calves, respectively, fed soy oil when compared with 
those of animals fed tallow. 
Many researchers have examined the effects of feeding 
polyunsaturated or saturated fats on cholesterol content of 
organs of animals to test the hypothesis that cholesterol may 
be redistributed to tissues in response to deposition of 
polyunsaturated fatty acids. This response may be one way in 
which polyunsaturated fatty acids partly mediate the 
hypocholesterolemic effects associated with them. Species 
researched include rats (Feldman et al., 1979), pigs 
(Baldner-Shank et al., 1987; Walsh et al., 1983), calves 
(Jacobson et al., 1974), and goats (Diersen-Schade et al., 
1984). Redistribution of cholesterol from plasma to organs 
of humans in response to eating diets high in polyunsaturated 
fatty acids was suggested by Grundy and Ahrens (1970). 
Redistribution of cholesterol, either over the long term (as 
indicated by cholesterol concentration in tissues) or in the 
short term (as indicated by the percentage of injected dose 
of ^H-cholesterol deposited) was not affected by type of 
dietary fat (the possible exception being perirenal adipose 
tissue); therefore, it is unlikely that redistribution of 
plasma cholesterol into tissues occurred in my study. 
The percentage of lipid in heart, liver, skeletal 
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muscle, perirenal and subcutaneous adipose tissues, and 
carcass were not influenced by diet (Table 4). The 
percentages of lipid in aorta and GI tract of pigs fed 40% of 
calories as fat was greater than those of pigs fed 20% of 
calories as fat. This effect may have occurred because the 
additional dietary energy consumed by pigs in the high fat 
diets caused pigs to store more energy as body lipid than did 
pigs fed low fat diets. However, percentage of lipid in the 
carcass does not support this. 
Table 4 also shows the percentage of injected dose of 
LDL-^H-cholesterol that was deposited in tissues. The 
percentage of dose deposited in aorta, liver, GI tract, 
subcutaneous adipose tissues, and carcass was not affected by 
treatment. The percentage of dose of injected LDL- H-
cholesterol that was deposited in muscle and heart was 
greater (P<0.10) in pigs fed 20% of calories as fat than in 
pigs fed 40% of calories as fat. Reasons for this are 
unknown. In addition, pigs fed diets high in soy oil had a 
greater deposition of LDL-cholesterol into perirenal fat than 
did pigs fed diets containing tallow or a blend of tallow and 
soy oil. For comparison Galloway et al. (1990) found 0.081%, 
0.063%, 0.086%, 0.057%, and 0.012% of injected dose of 
cholesterol in aorta, heart, liver, muscle, and viscera, 
respectively, 48 hours after a dose of LDL-^H-cholesterol was 
injected into pigs. 
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Very little research on human bile composition and flow 
rates as affected by dietary fat source are available because 
of ethical considerations in experimental design when using 
humans, often poor compliance to experimental protocol with 
human subjects, and lack of access to healthy humans 
implanted with bile duct catheters. Therefore, a model to 
study human bile metabolism is needed. The pig as a model 
system has many advantages, such as dietary compliance, 
adequate subject number, ability to engage in long-term 
experiments, less variation between experimental units, and 
opportunity for longer sampling periods. In addition, total 
biliary output can be collected from pigs, thereby allowing 
measures of flow rate and fluctuations of rate and biliary 
composition with time and diet. This would be a very 
difficult task in humans. 
Several questions, however, must be answered about the 
pig as a model for human bile metabolism. First, does bile 
flow and composition change in response to dietary changes in 
pigs in the same manner that it does in humans? Pigs may 
respond at lower concentrations of dietary fat than do people 
and then reach a plateau of response. It may be that 
experimental diets will need to be modified to contain a 
lower concentration of fat to use the pig as a model. 
Secondly, is the cholesterol concentration of bile in pigs 
less amenable to change than is that of humans? Pigs in my 
163 
study had a slightly lower concentration of biliary 
cholesterol than would be expected in humans. In addition, 
pigs do not spontaneously form gallstones and so seem to be 
capable of maintaining a lower lithogenic index of bile than 
can humans. Continued research is needed on use of the pig 
as a model for bile lipid metabolism in humans. 
In summary, type and amount of dietary fat did not 
influence concentration of cholesterol, bile acid, or 
phospholipid in bile or the bile flow rate. Fat source had 
inconsistent effects on the tissue measures reported. Many 
researchers have reported that bile acid precursors are 
derived primarily from high-density lipoprotein-cholesterol 
(Schwartz et al., 1978: Halloran et al., 1978) or from newly 
synthesized cholesterol (Robins et al., 1985; Bjorkhem and 
Lewenhaupt, 1979) rather from than LDL-cholesterol. One 
explanation as to why lipid secretion from LDL-cholesterol 
precursors into bile from pigs in this study was relatively 
unaffected by dietary fat source may be because the 
cholesterol source studied was associated with LDL particles. 
Continued research similar to the type described here is 
needed when using blood cholesterol in different lipoproteins 
for bile acid precursors or using different dietary fat 
sources to further elucidate how changes in bile metabolism 
can control body cholesterol homeostasis. 
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GENERAL SUMMARY 
This dissertation describes the second section of an 
experiment designed to test the effects of type (tallow, soy 
oil, or a blend of tallow and soy oil) and amount (20% and 
40% of calories as fat) of dietary fat fed to pigs on (1) 
concentration of free and total cholesterol, phospholipid, 
triacylglycerol, and protein in plasma and very low-density 
(VLDL), low-density (LDL), and high-density (HDL) 
lipoproteins, (2) concentrations of bile acids, cholesterol, 
and phospholipids in bile, (3) LDL-cholesterol deposition 
into tissues and secretion into bile as either bile acids or 
biliary cholesterol, (4) concentration of cholesterol and 
total lipid in selected tissues, (5) fatty acid composition 
of plasma, biliary phospholipids, and hepatocyte membranes 
and, (6) composition of postprandial lipoproteins. 
In the first section of the experiment, Faidley et al. 
(1990) reported that different dietary fats did not affect 
concentrations of cholesterol, triacylglycerol, or protein in 
plasma or major lipoprotein fractions. Concentration of 
phospholipid was less in plasma and VLDL of pigs fed diets 
containing soy oil. Weight percentage of cholesteryl ester 
was decreased in pigs fed diets containing soy oil when 
compared with pigs fed diets containing tallow. In addition, 
feeding tallow increased the percentages of myristic, 
palmitic, palmitoleic, and oleic acids in plasma. Feeding 
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soy oil increased the percentages of linoleic and linolenic 
acids in plasma. 
Results from the second section of the experiment 
indicate that dietary fat source did not affect bile flow 
rate or concentration of total bile acids, cholesterol, or 
phospholipids in bile. The newly developed assay used to 
determine concentration of biliary cholesterol is described. 
Diet also did not affect the secretion of LDL-cholesterol 
into bile as bile acids or cholesterol. Deposition of LDL-
cholesterol and concentrations of cholesterol and total 
lipids in tissues were affected inconsistently by type and 
amount of dietary fat. 
Diet did affect fatty acid composition of biliary 
phospholipids and hepatocyte cell membranes. Pigs fed diets 
containing tallow had greater percentages of palmitoleic and 
oleic acids and lesser percentages of linoleic and linolenic 
acids in biliary phospholipids than did pigs fed diets 
containing soy oil. Hepatocyte membranes collected from pigs 
fed tallow-based diets had greater percentages of myristic, 
palmitoleic, and oleic acids and a lesser percentage of 
stearic acid than did those collected from pigs fed diets 
containing soy oil. 
Lastly, effects of diet on postprandial lipoprotein 
composition were determined. Cholesterol content of LDL, 
triacylglycerol, phospholipid, protein content of HDL, and 
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triacylglycerol content of VLDL were affected to the greatest 
extent. Overall, type and amount of fat differentially 
affected the composition of lipoproteins from postprandial 
and fasted pigs, with amount of dietary fat having a greater 
effect than did type of dietary fat. In addition, 
lipoprotein composition did change with time after a meal but 
was not affected greatly by type of dietary fat. 
The public has been confused and concerned recently 
about nutrition issues, including dietary contents of 
cholesterol and saturated fatty acids, and the role they may 
play in cardiovascular and overall health. Many philosophies 
about nutrition exist, and they span the spectrum from 
extreme control over dietary intake to moderation to no 
concern for dietary intake. People are understandably 
confused when faced with so many opinions from so-called 
experts. My hope is that my research may help nutritionists 
make the correct recommendations, especially where animal 
products are concerned. We must begin to consider the 
saturated fatty acid content and nutritional value of foods, 
especially animal products, before they are condemned. In 
addition, nutritionists must begin and continue to consider 
the saturated fatty acids separately rather than in one class 
that is labelled "hypercholesterolemic". 
Research abounds on the effects of dietary constituents 
on blood cholesterol concentration and coronary heart disease 
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(CHD). Future research must look beyond the cause and effect 
relationship of LDL-cholesterol concentration and CHD to how 
cholesterol affects health of the heart and to consider ways 
to decrease concentration of LDL-cholesterol. We must 
continue to study cholesterol excretion from and storage in 
the body, cholesterol synthesis, and how diet can affect the 
very complex biochemical and physiological pathways involved 
in cholesterol homeostasis. 
Several suggestions for future research can be made. 
First, we must prove that the pig provides an excellent model 
for humans when studying bile metabolism as it relates to 
cholesterol homeostasis. Once this model is established and 
accepted, there are a number of avenues that can be pursued. 
One suggestion would be to determine how source of 
cholesterol used for biliary lipid precursors affects bile 
composition. Research in this area is beginning. Secondly, 
how do different dietary fats affect the liver functions 
associated with cholesterol and bile acid metabolism, 
including, but not limited to, effects on the LDL-receptor, 
HMG-CoA reductase activity, and activity of 7a-hydroxylase, 
the enzyme that catalyzes the first limiting step in bile 
acid synthesis? To my knowledge, effects of dietary fat on 
7a-hydroxylase activity in the liver have never been studied. 
Suggestions for studies that consider the whole animal 
also can be offered. The pig model should work very well to 
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study the effects of diet on bile composition over time with 
repeated samples beginning at the time of change in the diet 
and continuing over an extended period. Studies that include 
long-term, serial sampling may provide clues as to the 
efficacy of dietary changes that are being suggested to 
humans for their lifetime. Interactions of dietary 
constituents also should Le considered. Much research has 
been completed on the interaction of dietary fat and protein, 
but little has been done on thé interaction of dietary fats 
with different fiber sources. In addition, there is a 
plethora of research comparing the effects of saturated fats 
with unsaturated fats on plasma cholesterol, but little 
published research comparing different saturated fat sources. 
Of special interest would be a comparison of tropical oils 
with fats from animal sources. 
The last suggestion,would be to consider the effect of 
different dietary fats on postprandial lipoprotein 
composition, interaction, and catabolism. Humans are in a 
postprandial state for a major portion of the day, but there 
is little research done at the present time to clarify how 
dietary fat intake, either in the long or short term, affects 
lipoprotein metabolism after a meal. 
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